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ABSTRACT
A n  e x a m i n a t i o n  o f  t h e  r e l a t i o n s h i p  b e t w e e n  t h e  p r e v a l e n c e  o f  
m u l t i p l e  s c l e r o s i s  a n d  t h e  g e o l o g i c a l  e n v i r o n m e n t  -  s p e c i f i c a l l y
EXPOSURE TO RADON BEFORE THE AGE OF 1 5  YEARS 
DENIS CARROLL 2005
M u ltip le  S c lero sis  (M S ) is  o n e  o f  th e  m ost co m m o n  d isea ses  o f  th e  C entral 
N e r v o u s  S ystem , w ith  n o  k n o w n  cau se  o r  cure. It is  a  p ro g ressiv e  d egen erative  
d isea se  and it a ffects p e o p le  all around th e  w orld . It is  o n e  o f  th e  m ost co m m o n  
disabling n eu ro log ica l co n d itio n s o f  y o u n g  adults, a ffectin g  a lm ost tw ic e  as m any  
w o m e n  as m en. It has b een  d iagn osed  m ore frequently  s in ce  1970s.
W orld w id e  ep id em io lo g ica l and g en e tic  su rveys in d icate  that M S  is  ca u sed  b y  an  
interplay b etw een  g en e tic  traits and environm ental in flu en ces. T o  date, n o  k n o w n  
environm ental agen t has b een  identified . E stim ates o f  to ta l num ber o f  c a se s  in  
Ireland are in  th e  reg io n  o f  4 ,0 0 0  to  6 ,5 0 0 , su g g estin g  a p reva len ce  rate o f  1 0 0 -  
1 6 2 /1 0 0 ,0 0 0 , h o w ev er , th ere is  no reliable national database o f  p e o p le  w ith  M S .
T his study w a s  d esign ed  to  exam in e th e  environm ental m ilieu  o f  p e o p le  w ith  M S , 
v ia  a questionnaire d istributed w ith  M S  N e w s  to  o v er  5 ,0 0 0  M S  N e w s  subscribers. 
T h e 671  resp o n ses rece iv ed  w e r e  analysed  under v a r io u s head ings including: 
g en d er (F :M  =  2 .2 :1  ); a verage  a g e  at d ia g n o sis  (3 6 .8  years); relatives w ith  M S  
(o v e r  22% ); typ e  and lo ca tio n  o f  h o u se  (40%  sin g le  s to rey ) and sc h o o l (65%  sin g le  
storey).
B a sed  on  com p arison  w ith  th e  study o f  D o n e g a l and W ex fo rd  b y  M cG u ig a n  et al. 
(2 0 0 4 ) , an estim ated  p reva len ce  rate o f  1 6 4 .2 5 /1 0 0 ,0 0 0  h as b een  ca lcu la ted  for th e  
w h o le  country.
R ad on  lev e ls  (R P II data) and Interferon  prescrib ing patterns w ere  a lso  exam ined . 
T he study ob served  clu ster in g  o f  M S  c a se s  in  areas that are k n o w n  to  h a v e  high  
R a d o n  em ission s and a  sparser d istribution  o f  c a se s  in  lo w  R a d o n  em itting  areas, 
and th erefore, co n c lu d es  that th e  p oten tia l to  d ev e lo p  M S  is  greater i f  e x p o se d  to  
h igh  R ad on  lev e ls  in ch ild h ood , esp ec ia lly  fo r  m ales, and that th e  rise in in c id en ce  
sin ce  th e  1 9 7 0 s  has co in c id ed  w ith  greater ex p o su re  to  in d o o r  R adon.
K e y  w o rd s: M u ltip le  S c lero sis , R adon , environm ent, Ireland, estim ated  p reva len ce
1. INTRODUCTION
1.1  I n t r o d u c t i o n
A n y o n e  w h o  en cou n ters M u ltip le  S c lero sis  (M S ) inev itab ly  ask s, “w h a t are the  
cau ses?  and w h y  th is p erson , at th is tim e and in th is  p lace?” D e sp ite  ex ten siv e  
studies, esp ec ia lly  o v e r  th e  last 5 0  years, m any q u estio n s  rem ain u n an sw ered . 
This study w a s d esign ed  to  in v estig a te  th e  ep id em io lo g y  o f  o n e  asp ect o f  M S .
1 .2  O b j e c t i v e s  o f  S t u d y  
T he o b jectives o f  th is stu d y  w ere
a. T o  estab lish  th e  p reva len ce  o f  M S  in  Ireland
b. T o  estab lish  th e  environm ental m ilieu  o f  M S  patien ts fo r  th e  first
15 years o f  their lives
c. T o  p lo t th is in form ation  geograp h ica lly
d. T o  exam in e th e  relationship  b e tw e e n  th e  in c id en ce  o f  M S  and
factors in creasin g  ex p o su re  to  natural radiation w ith in  th e  built 
environm ent, (sp ec ifica lly  -  in d oor radon)
e. I f  th e  h yp o th esis  is  p ro v en  - to  alert national authorities as to  w hat
p reven tative  or m itigatin g  action s can  b e  taken.
1 .3  M u l t i p l e  S c l e r o s i s  R e s e a r c h  O v e r v i e w
T h e history, or  m ystery, o f  M S  reads like a d e tec tiv e  n o v e l spanning m o re  than a  
century, and to  date m any c lu es  h ave b een  put to g eth er . T h e  an sw ers are s lo w ly  
em erging , but there is  still m uch  m o re  w o rk  to  b e  d on e, in order to  so lv e  the  
m ystery o f  M S .
E ver  sin ce C harcot first described  th e  d isea se  n o w  called  M u ltip le  S c lero s is  (M S )  
in 1868 , research  has b een  o n g o in g  in to  th e  a e tio lo g y  o f  th is d isease. It has b een  
described  as an  auto im m une d isea se  i.e ., th e  b o d y ’s d e fen ce  m echanism , w h ich  is 
design ed  to  reco g n ise  s e lf  from  n o n -se lf, turns from  d efen d er to  attacker and  
attacks th e  m yelin  sheath  that co a ts  th e  nerves. T o  date n o  k n o w n  ca u se  or cure  
has been  found. T his has b een  frustrating fo r  b oth  th e  health  sc ien ce  com m u n ity  
and m ore particularly, for th o se  d ia g n o sed  w ith  M S . M S  has b een  lo n g  a sso c ia ted
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w ith  geograp h y , in sofar  as in c id en ce  in creases w ith  d istan ce  from  th e equator. 
T his project w ill fo c u s  o n  th e  ep id em io lo g y  o f  M S  and radiation  in its  
geograp h ical setting. I w ill exp lain  w h at M S  is, h o w  it a ffects  on e, and from  
w h ere  it is  th ou gh t to  h ave orig inated . T h e g lob a l d istribution  o f  M S  w ill b e  
described , w ith  already reco g n ised  patterns. T h is stu d y  w ill te st th e  h y p o th esis  
that R ad on  ex p o su re  in  th e  first fifteen  years in flu en ces th e  o n se t o f  M S  in later  
life. It is h op ed  to  d em on strate  that th ere  m ay b e  an a sso c ia tio n  b etw een  th e  lik e ly  
ex p o su re  to  in d o o r  R a d o n  and o n se t o f  M S  in g en etica lly  su scep tib le  individuals.
1 .4  B a c k g r o u n d  t o  S t u d y
M y  asso c ia tio n  w ith  th is  project stem s from  th e p ilo t stu d y  that w a s  carried o u t by  
D r. M argaret G ilm ore and M r. E am on n  G rennan, b o th  lecturers in IT  S lig o , 
w h o se  back grou n d s are resp ectiv e ly  in  M ed ic in e  and G eo lo g y .
T he northw est o f  Ireland appears to  have on e  o f  the highest prevalence rates o f  M S  
in  Ireland. This is speculative, as there is  n o  reliable national database. T he area is 
on e o f  the highest radon-em itting areas in Ireland, w ith  D on ega l in particular 
containing som e o f  the m ost highly uranium enriched granites in the country. This 
provided the m otivation  for the pilot study that w a s undertaken, i.e. an attem pt to  
refine the w ell-k n ow n  geographical association  b etw een  M S  and tem perate clim ates 
to  a m ore coherent association  betw een  M S  and g e o lo g y  (G ilm ore and G rennan, 
2 0 0 3 ).
F rom  ep id em io lo g ic  stu d ies, it has b een  th ou gh t that there is  a  tr igger  in early  life, 
p ossib ly  in th e  first f ifteen  years, in gen etica lly  su scep tib le  individuals, w h ich  is 
responsib le  fo r  the o n se t o f  M S . A  ch ild h ood  v irus has lo n g  b een  co n sid ered  on e  
o f  th e  m ain triggers. T o  date n o  virus h as b een  p o sit iv e ly  identified  as b e in g  th is 
trigger.
1 .5  D i s e a s e  a n d  G e o l o g y
T he link b etw een  d isea se  and g e o lo g y  is noth in g  n ew , for exam ple;
a. co a l m in ing -  s ilico sis
b. m ining or p ro cessin g  a sb esto s  -  a sb esto sis
c. radon -  lu n g  cancer
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d. Uranium enriched granites - multiple sclerosis, as postulated by 
Bolviken, Nilsen and Ukkelberg (1997).
In this current study the hypothesis is posed that radon (a decay product o f 
uranium) exposure, may trigger MS in susceptible individuals, who are exposed to 
it before the age o f 15 years.
If  exposure to indoor radon is shown to be an environmental trigger, then it would 
follow that by eliminating or mitigating exposure to this known contributor to ill 
health, MS may be preventable, in some if not all o f its forms in certain 
individuals.
Radon gas is generated in the earth’s crust by the radioactive decay o f uranium 
within e.g. granites many kilometres below the surface. Radon may become 
trapped within buildings; it is nine times heavier than air and therefore is more 
concentrated at ground levels. It follows logically that bedrooms at ground floor 
level permit a greater degree o f exposure, as would floor play by children. Radon 
has an accepted association with lung cancer, and it is known to be soluble in fat. 
The myelin tissue coating the nerves in MS is fatty tissue.
1.6 Results
The results o f this study are based on the findings o f a questionnaire that was 
distributed via the MS News magazine to people with MS, with a view to 
establishing their environmental milieu during the first fifteen years. Brady, Dean, 
Secerbegovic, S. and Secerbegovic, A. (1977) in their paper “Multiple Sclerosis in 
the Republic o f Ireland” suggested “a study based on the birthplace o f MS 
patients”.
In this thesis, data on Multiple Sclerosis and Radon will be presented, as will the 
results from the analysis o f the questionnaires.
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2. L it e r a t u r e  R e v ie w
2.1 Multiple Sclerosis
2.1.1 Origins and History of Multiple Sclerosis
The first written record o f someone with MS type symptoms refers to the Dutch 
patron Saint o f ice skaters, “Lydwina o f  Schieden” (1380 -  1433), 
(http://www.mult-sclerosis.org/famous.html) and (http://www.albany.net/~tjc/ms- 
tory.html). Medical drawings from the late 1830’s show what is today recognised 
as MS. However, the first scientific description and clinical symptoms that are 
today known as “Charcot’s Triad”, diplopia (double vision), ataxia (disturbances 
o f balance or co-ordination) and dysarthria (difficulties with, or slurred speech) 
were recorded by Dr. Jean Martin Charcot (1825 -  1893), who is often referred to 
as the “Father o f Multiple Sclerosis” .
One o f his many students was a man named Sigmund Freud (1856 -  1939). Freud 
treated his former Nanny who had what was then known as “Creeping Paralysis”, 
thought to be a mental condition caused by “Female Hysteria". This misdiagnosis 
probably explains why little research into MS was conducted until modem times.
MS was originally thought to be more prevalent in men, due to women being 
diagnosed with “Female Hysteria’’. There is a tendency for MS symptoms to flare 
each month for many female sufferers. “In a sample o f  149 women with MS, 70% 
o f the women said they noted an increase in their neurologic symptoms several 
days prior to onset o f menses. Three or four additional studies o f self-reports, 
support this observation”, (http://www.nationalmssociety.org/Brochures- 
Hormonesl.asp).
Louis Ranvier discovered myelin, the fatty tissue that coats the nerves in 1878. In 
1925, Lord Edgar Douglas Adrian helped prove that demylinated nerves are 
unable to carry the electrical impulses by recording the first electrical nerve 
transmissions, (http://www.ifmss.org.uk/en/research/history_of_ms_research/co- 
mplexitiesand.html) and (http://www.albany.net/~tjc/mstory.html).
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Myelinated Nerve Fibers
Normal Myelin Sheath
Myelin Sheath
Nerve fiber 
(Axon)
Electrical Impulses 
Damaged Myelin Sheath
Electrical impulses “leak-cut’’ 
and the message does not transmit
Fig. 2.1 Myelinated Nerve Fibres
Source: Lexi Comp Inc USA Diseases Explained 
http://www.diseases-explained.com/MultipleSclerosis/whatisms.html
Myelin sheath Absence of 
myelin sheath
Muscle Fibre
Fig. 2.2 Electrical Impulse from Nerve to Muscle 
Source: http://www.ahealthyadvantage.com/topic/ms
In the above illustration, the electrical impulse from the nerve cell may not reach, 
or only partially reach the muscle, that it is attached to, due to demyelination, 
thereby causing the muscle to malfunction (shaking) or not function at all.
2.1.2 Description of Multiple Sclerosis
MS is a disease o f  the central nervous system (CNS), i.e. the nerves that comprise 
the brain and spinal cord. There is no known single causative factor associated
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with the development o f MS, therefore there is no way o f knowingly preventing 
it, nor can it be cured. It is one o f  the most common diseases o f the CNS. Its
In multiple sclerosis 
the myelin sheath, 
which is a single cell 
whwe membrane wraps 
around the a w ,
1» destroyed with 
Ififlftmrrurtlon
Fig. 2.3 Brain and Spinal Cord 
Source: medline plus
http://www.nlm.nih.gov/medlineplus/ency/imagepages/17089.htm
mechanism remains obscure and elusive; it is considered to be an autoimmune 
disease, attacking the myelin sheath that wraps around the nerves. It affects 
approximately twice as many women as men, as do most autoimmune diseases 
and there also exists a familial pattern. The pathogenesis o f MS has been 
attributed to: - infectious agents, environmental exposure, genetic susceptibility 
and even dietary factors. Viral infections have been suspected o f having an 
influence on developing MS and this is attributed to their known ability to  cause 
demyelination in both humans and animals. Hogancamp, Rodriguez, and 
Weinshenker, (1977) and Ebers and Sadovnick (1993) in their studies into the 
epidemiology and geographic distribution o f MS, support the theory that both 
genetics and environment play a part in the development o f MS. Compston (2004) 
has hypothesised that MS evolved from a somewhat related disorder, Devic’s 
disease, or Neuromyelitis Optica.
2.1.3 Pathology
The CNS contains millions o f  nerve cells joined together by long thin fibres. The 
electric signals start in the nerve cells and travel along these fibres to and from the 
brain. A fatty substance called myelin covers these fibres. This myelin (which
Central nervous system 
(brain and lplnal cofd)
Mdscarrtog
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works in a similar way that insulation works on electrical wire) becomes damaged 
and the connection with the nerve fibres is disrupted, resulting in lost, blocked or 
delayed signals travelling to and from the brain. Hardened tissue called scar tissue 
forms on the nerve fibres; this process is called “sclerosis”, a Latin word meaning 
scar and that is how the disease gets its name. Multiple refers to the multiple sites 
that are scarred, leading to a multiplicity o f symptoms (Herndon, 2003).
MS is a progressive degenerative disease and it affects people all around the 
world. According to the World Health Organisation (WHO) and the National 
Multiple Sclerosis Society (USA), it affects 2.5 million people worldwide. 
Kurtzke (1977) described it as a geographically related disease, more common in 
Caucasians. MS development is related to place o f residence before 15 years of 
age (Dean and Elian, 1997). The true cause or causes o f the disease are still 
waiting to be discovered. However, if  a cause can be identified, and is eliminated, 
then MS may be preventable.
2.1.4 Types of Multiple Sclerosis
There are several recognisable patterns o f MS that are described below
2.1.4.1 Benign Multiple Sclerosis: Affects approximately 20% o f MS population, 
(http://www.albany.net/~tjc/multiple-sclerosis.html), or affects 10% o f MS 
population (www.msmeans.ca/faqs.html), depending on which expert you are 
consulting. Following one or two attacks, there is a complete recovery and no 
discemable disability. There is no permanent disability for the majority in this 
category; however, some people in this category will experience disease 
progression, evolving into the more progressive stages of MS as time passes, 
some ten to fifteen years hence.
2.1.4.2 Relapsing-Remitting: Affects approximately 25% o f MS population. 
(http://www.albany.net/~tjc/multiple-sclerosis.html), or again depending on who 
is being quoted, 50% (www.msmeans.ca/faqs.html), and follows a pattern of 
unpredictable, recurrent attacks during which existing symptoms may become 
more severe or new symptoms may appear. This is followed by a gradual 
recovery, generally over weeks or months. Any impairment will not worsen
7
between attacks. During this stage o f  the disease, there may be long stages where 
there are no discemable symptoms, however the disease is not dormant and there 
is ongoing damage occurring. This can be considered the most common 
“beginning phase” o f the disease. Some 50% of cases will have progression 
within ten to fifteen years and an additional 40% within twenty-five years o f onset 
(http://www.albany.net/~tjc/multiple-sclerosis.htmy. This form o f the disease then 
evolves into Secondary Progressive.
2.1.4.3 Secondary-Progressive: Evolving from the relapsing-remitting stage and 
affecting approximately 40% of MS population. (http://www.albany.- 
net/~tjc/multiple-sclerosis.html#S/P). Recovery from this stage is not as complete 
as previous stages and the disability becomes permanent. There is an apparent 
lessening o f clinical attacks and they become less pronounced with little or no 
remission. This type is associated with more and more central nervous system 
tissue being destroyed.
2.1.4.4 Primary-Progressive: Affecting approximately 12% of sufferers 
(http://www.albany.net/~tjc/multiple-sclerosis.html), and is characterised by 
gradual and increasing impairment. There are no distinct remissions, but periods 
o f relative stability can occur. While not common in younger individuals, this is 
the most common pattern in late onset cases (i.e. onset after age 40). In this type, 
unlike the exacerbating remitting types in which the female to male ratio is 
generally 2:1, the ratio is only about 1.3:1 (Herndon, 2003).
2.1.4.5 Progressive-Relapsing: Presenting a progressive pattern o f impairment 
(once known as Marburg MS), with periods o f more rapid deterioration and 
affecting approximately 3% o f people with MS (http://www.albany.net/~tjc/mul- 
tiple-sclerosis.html). It is the more complex form o f the disease, although it is 
similar in terms o f disability to primary progressive. It is probably the most 
dreaded form o f the disease, as lost function never returns. Its severe unrelenting 
progression can lead to death within a few months to a year (Herndon, 2003).
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2.1.5 Diagnostic Categories for Multiple Sclerosis
During the early stages o f MS, the symptoms experienced may not be recognised 
as being associated with MS. They may be mistaken for other conditions that have 
similar symptoms. As there is no specific non-intrusive diagnostic test for MS, 
(Fangerau, Schimrigk, Haupts, Kaeder, Ahle, Brune, Klinkenberg, Kotterba, 
Mohring, and Sindem, 2004) and given the unpredictable nature o f the disease, it 
can be difficult to confirm.
MS is likely to begin with a string o f fluctuating, difficult to describe, and what 
seem to be minor, symptoms that are often forgotten about. They seem to clear up 
without treatment, but continue to return periodically. Many of the symptoms can 
be attributed to several different medical conditions, e.g. Lindane Poisoning, as 
illustrated in Table 2.1 below.
Lindane, formerly known as gamma benzene hexachloride is an insecticide used 
to treat scabies and head lice infestations. It is also widely used to control insect 
infestations on livestock, pets and agricultural products. It has been banned in 
several countries and is severely restricted in others, (http://www.drrichard- 
hall.com/lindane.htm). It has been described as a persistent organic pollutant by 
UN Environment Programme and has been classified as a possible human 
carcinogen, (http://www.foodcomm.org.uk/pesticides_lindane.htm)
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Table 2.1 Comparison of Symptoms
Symptoms of Lindane poisoning compared to symptoms of MS
|Lindane poisoning symptom MS symptom
Seizures Acute flare-ups
Weakness Fatigue
Paresthesia of face and 
extremities
Numbness of extremities
Giddiness Giddiness
Impaired memory Short term memory loss
Loss of sleep Sleeping disorders
Headaches Headaches
Abnormal EEG patterns Abnormal EEG patterns
2/3 women affected 2/3 women affected
Vertigo Dizziness (Erratic walking)
Trauma induced Trauma induced
Loss of libido Loss of sexual urge
Malaise
Feeling of discomfort or 
uneasiness
Tremors Tremors
Apprehension Uneasy, Anxious
Decreased nerve velocity Decreased nerve velocity
Musculoskeletal effects Musculoskeletal dysfunction
Source: http://www.protector.pair.com/ms/
A considerable time may pass before MS is confirmed or even mentioned. 
However, a diagnosis o f  MS may be more definite if  the patient presents with a 
concise history o f attacks, coupled with known symptoms o f MS. What the 
neurologist requires is clinical evidence that the symptoms point to at least two 
different areas o f the CNS and at least two distinct attacks with a specific 
timeframe between attacks. All other neurological causes have to be eliminated.
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2.1.6 Poser Criteria
The Poser criteria for diagnosing MS were put forward in 1983 to update the 1965 
Schumacher criteria (http://thjuland.tripod.com/diagnosis.html). McDonald also 
developed criteria for diagnosing MS in 2001, however, Fangerau et al. (2004 p. 
385) concluded that, “MS according to the McDonald criteria was diagnosed more 
often than 'clinically definite MS' according to Poser et al., but combining the 
categories o f clinically and laboratory definite MS, the diagnosis o f MS could 
clearly be established more frequently using the Poser criteria” . Therefore, only 
the Poser criteria are included in this thesis.
2.1.6.1 Definite Multiple Sclerosis
a. Consistent course, relapse/remitting, with at least two bouts, 
separated by at least 1 month; or slow, stepwise progressive course 
for at least six months.
b. Documented neurological signs o f lesions in more than one area o f 
brain or spinal cord white matter.
c. Onset o f  symptoms between ten and fifty years o f age.
d. Absence o f other more likely neurological explanations.
2.1.6.2 Probable Multiple Sclerosis
a. History o f relapsing/remitting symptoms.
b. Signs not documented and only one current sign commonly
associated with MS.
c. Documented single bout o f symptoms with signs o f more than one 
white matter lesion.
d. Good recovery, then variable symptoms and signs.
e. Absence o f other more likely neurological explanations.
2.1.6.3 Possible Multiple Sclerosis
a. History o f relapsing/remitting symptoms.
b. No documentation o f signs establishing more than one white
matter lesion.
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c. Absence of other more likely neurological explanations.
2.1.7 Symptoms
The symptoms can vary from time to time and from individual to individual and 
can include: bladder dysfunction, bowel dysfunction, cognitive problems, speech 
and swallowing disorders, dizziness, fatigue, walking problems, headaches, 
hearing loss, vision problems, numbness, pain and seizures. (Medline: 
http://www.nati0nalmss0ciety.0rg//Sympt0ms.asp). Martyn (1991) in a review o f 
published reports, observed the incidence o f initial symptoms as:
a. weakness in one or more limbs 40%
b. optic neuritis (inflammation o f nerves) 22%
c. paraesthesiae (tingling, pins and needles) 21%
d. diplopia (double vision) 12%
e. vertigo 5%
f. disturbance o f micturition (urination) 5%
Since the myelin can be attacked in any area o f the CNS, the symptoms vary 
accordingly. The disease, which has been described as an autoimmune disease, i.e. 
the immune system which is designed to recognise self from non self, turns from 
being a defender to an attacker, and attacks the myelin sheath that insulates the 
nerves.
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2.1.8 Features Observed in Multiple Sclerosis
The course is unpredictable but some associated features that are known are 
described below.
2.1.8.1 Age
“MS is the most common disabling neurological condition o f young adults, 
affecting approximately 6,000 people in Ireland” (http://www.ms- 
society.ie/what/index.html). The average age at onset is not easy to  determine. In 
approximately 70% o f patients onset occurs between 20 and 40 years o f age 
(Simon, 2002). Cottrell, Kremenchutzky, Rice, Koopman, Hader, Baskerville and 
Ebers, (1999) reported a mean age o f onset o f 38.5 years. An interesting finding 
by Kurtzke, Page, Murphy and Norman, (1992) in their study o f over four 
thousand WWII veterans, found the average age at onset for white men was 27 
years, 27.7 years for white women and 27.5 years for black men. These average 
ages rose as one travelled from north to south in the USA, thus the further south 
one lived the higher the average age at onset. They divided the USA into three 
horizontal tiers, a northern, middle and southern tier. They divided the MS 
patients by entry into service by state and found that the average age at onset for 
white men was 26.4 for northern tier, 27.3 for middle tier and 28.8 for the 
southern tier. Similar trends were observed for white women and for black men. 
There was no mention o f black women in this study.
2.1.8.2 Gender
It is generally accepted that MS affects more women than men, although reported 
ratios differ from 1.3:1 to 2.79:1. As cited by Gilmore and Grennan (2003) 
Robinson (1988) and Benz (1988) suggest that the ratio was on average 3:2, while 
Bumfield (1991) suggests a ratio o f 1.7: 1. Ford, Gerry, Airey, Vail, Johnson, and 
Williams, (1998) found a ratio o f 2.8: 1. A study by McDonnell and Hawkins 
(2000) in Northern Ireland reports a ratio o f 2.1: 1. Totaro, Marini, Cialfi, Giunta, 
and Carolei, (2000) found a rate o f  2:1. The pilot study carried out in the 
Northwest o f Ireland by Gilmore and Grennan (2003) suggests a ratio o f 1.6:1. 
Cottrell et al. (1999) reported a significantly lower ratio o f 1.3:1.
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Data obtained from the Department o f Social, Community and Family Affairs, 
Ireland, (2004) lists the number o f people claiming disability benefit due to MS 
and shows quite a different picture. The figures given were 133 females and 41 
males, a ratio o f 3.2:1. However, it must be borne in mind that disability benefit is 
paid out over the short term, and then the individual is transferred to disability 
allowance, a long-term payment.
2.1.8.3 Ethnicity
MS can be found worldwide but is most common amongst Caucasian people o f 
northern European origin, particularly those o f Scottish descent (Rothwell and 
Charlton, 1998 and Rosati, 2001). Within the African and Asian populations, it is 
quite rare. Canadians living in the same regions as indigenous Inuit people have up 
to twenty times the Inuit prevalence rate. Among the Native American population, it 
is also relatively rare, as it is in the Aborigines and Maoris o f Australia and New 
Zeland respectively (http://en.wikipedia.0rg/wiki/Multiple_scler0sis#Prevalence),
2.1.8.4 Geography
The risk for MS varies throughout the world. In general, MS is more prevalent in 
temperate regions than in the tropics. Prevalence is highest in northern and central 
Europe (except northern Scandinavia), Italy, southern Australia, New Zeland, and 
the northern regions o f the USA and Canada. Middle-risk areas are southern 
Europe (except Italy), southern USA, northern Australia, northern Scandinavia, 
and the Caucasian populations o f  South Africa (Kurtzke, 1977 and Pozzilli 
Romano and Cannoni, 2002).
Low-risk areas include most parts o f  Africa and Asia, the Caribbean, Mexico, and 
possibly northern South America. Several theories have been put forward to 
explain this pattern, citing environmental factors, genetics, and/or a combination 
o f both. Kira (2003) noted that the cause o f MS can be attributed to an interplay 
between genetic traits and the environment, and is borne out by epidemiological 
and genetic surveys. The top ten countries today measured by prevalence rate (per 
100,000) are: -
a. UK (143.8)
b. Sweden (134.8)
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c. Ireland (125.0)
d. Denmark (112.0)
e. Canada (111.0)
f. Iceland (105.1)
g Germany (99.0)
h. Finland (98.0)
i. Czech Republic (97.1)
j- Holland (94.9)
(source : http : //www. mult-sclerosis. org/explainingms. html).
Fig. 2.5 Global Prevalence o f MS
(source http://www.mult-sclerosis.org/ms_world.html)
The first mention that MS prevalence rates increased with distance from the 
equator was by Limburg in 1950 cited in Ford et al. (1998). “There is good 
international evidence o f geographical variation in prevalence, best described by 
increasing prevalence with latitude, both north and south o f the equator” 
(Richards, Sampson, Beard, and Tappenden, 2002 p. iii). Poser (1995) suggests 
that the direct relationship between latitude and prevalence rates can no longer be 
considered valid and although he does not speculate on what the environmental 
factor might be, he does acknowledge its existence. It is perhaps just a 
coincidence that the distribution o f MS reflects a latitudinal variation. This idea 
will be revisited. Rothwell and Charlton (1998 p. 730) state “the prevalence o f
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MS increases with latitude north and south o f the equator”, and further that this 
could be caused by exposure to a causative environmental agent. The causative 
environmental agent seems to be gaining more ground, Ebers and Sadovnick 
(1993) in their conclusion noted that there is no known single environmental or 
genetic factor that explains the geography o f MS and McDonald (1986) noted 
that the environmental factor needed to explain MS still remains obscure.
The differences in prevalence rates observed among different ethnic groups in 
similar locations, seem to suggest, that along with genetic factors, there may be 
enhancing and/or protective influences which are probably environmental in 
nature (Poser, 1995). Even in areas o f low prevalence, e.g., Japan, Kira (2003), 
noted a small, but considered it to be a significant north to south gradient o f MS 
prevalence rates, and believes that it is something in the environment that 
contributes to developing MS. Rosati (2001) also questions the traditional beliefs, 
on prevalence/latitude, by looking at the updated distribution o f MS in Europe, 
which shows many exceptions to the previously described north-south gradient. 
This observation requires a more thorough explanation than simply a prevalence- 
latitude relationship. Wallin, Page, and Kurtzke, (2004) observed marked changes 
in the distribution o f MS and this they suggest implies a primary environmental 
factor, and again no suggestion as to what the environmental factor might be. 
Dean and Elian (1997 p.565) concluded “that the environment during childhood is 
a major factor in determining the risk o f developing M S”.
Rosati (2001) acknowledges the difficulty in trying to explain the pattern of 
geographical differences in MS frequency. Closer to home in a recent study by 
(McGuigan, McCarthy, Quigley, Bannan, Hawkins and Hutchinson, (2004) they 
concluded that the latitudinal variation in the prevalence o f MS rates between 
Donegal and Wexford was more likely explained by greater accuracy in 
diagnosing and/or better case ascertainment. A combination of genetic and 
environmental factors appears to be needed to  explain the data on MS and 
Geography.
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2.1.8.5 Genetics
Descriptions o f  MS in Scandinavia in the early 18th Century are recounted by 
Pozzilli et al. (2002), however, the first written record dates back to the 14th 
Century in Holland (http://www.albany.net/~tjc/ms-tory.html). It appears to have 
spread across the Baltic States, Northern Europe, and the British Isles over the 
next 100 years or so, and then on to North America, Australia and Italy. Poser 
(1995) proposes that MS is a disease o f the Scandinavians, as they raided most o f 
Europe and engaged in trade with the Arabs. All this contributed to the genetic 
distribution o f the MS gene or genes.
MS can be described as a complex genetic disorder. Following years o f research, no 
single gene has been identified as being the cause o f MS. Several genes have been 
implicated. Compston (1999) has suggested that interplay between genetic and 
environmental factors is likely in the onset of MS, with a familial recurrence rate o f 
15%. Compston’s studies into the genetics of MS go back over 15 years and he 
currently leads the Multiple Sclerosis Genetics Group based in Addenbrooke's 
Hospital, Cambridge. In April 2000 various groups researching native and migrant 
European populations came together to identify possible susceptible genes and this 
collaboration resulted in the Genetic Analysis o f Multiple Sclerosis in Europeans 
“GAMES”. A total o f 19 GAMES projects have been completed and involved 16 
native European and migration European populations.
A large study o f Canadian twins (370 pairs), has confirmed that genes and 
environment both contribute to onset o f  MS (Wilier, C. J., Dyment, D.A., Risch, 
N.J., Sadovnick, A. D. and Ebers, G. C. 2003). Chataway, Mander, Robertson, 
Sawcer, Deans, Fraser, Broadly, Clayton, and Compston (2001 p. 757) agree, 
“genes influence both susceptibility and evolution in MS” and they also recognised 
the familial tendency. The Canadian Twin Study that spanned two decades has 
confirmed that the overall risk for identical co-twins is 25%. When both twins were 
male, the risk dropped to 5% and rose to 34% when the twins were female. The 
study also found that the majority o f identical twins with MS are female. The risk for 
non identical twins was 5.4%. This would indicate that the disease runs in families, 
although the risk o f someone inheriting all the genetic factors is low. However, as
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Compston (1999) points out, if both parents have MS, prevalence in children is 
higher than if only one parent has MS.
Scientists have identified a gene, which appears to be a risk factor and may 
contribute to more rapid progression than normal. They also found that people 
who have two copies o f a particular variant o f the gene, known as CD24, were 
significantly more likely to develop MS than other people in the study (Zhou, 
Rammohan, Lin, Robinson, Li, Liu, Bai, Yin, Scarberry, Du, You, Guan, Zheng 
and Liu, 2003).
2.1.9 Environment
The environmental link between where a person spent their first fifteen years and 
the likelihood o f developing MS in later life has been well established, most 
recently by Dean and Elian (1997). This has been borne out by migration studies, 
which show that migration after 15 years o f age, the risk o f the area moved from 
is retained. This is based on their (Dean and Elian 1997) study o f immigrants to 
England from Asia and the Caribbean. They found that MS is rare among the 
Chinese, finding only two cases o f  MS among an estimated 45,000 Chinese 
immigrants. They also found that Pakistani and Indian immigrants who migrated 
to England younger than 15 years had a higher risk o f developing MS than those 
who migrated after 15 years. On the reverse side, those bom in a high risk area 
and who move to a low risk area, after the age o f 15 years, retain the high risk, as 
cited by Dean’s (1969/70) studies o f British migrants to South Africa.
2.1.10 Treatment
One o f the reasons why people with MS have tough decisions to make as regards 
treatment is the fact that their disease may be progressing even though there are 
no visible symptoms, and whilst it might go against the grain to take drugs when 
there is no apparent problem, medical science tells us that waiting is not a good 
approach. The main form o f treatment for MS is drug therapy, including the 
interferons, Beta la  and Beta lb  (see ABC treatments in table 2.2)
The latest bad news for MS patients is the withdrawal o f the Biogen/Elan drug, 
Tysabri. However, this drug is not, nor has it been on the market in Ireland as it 
has not yet been licensed in Europe. There are however up to 20 patients involved 
in trials in Ireland (http://Avww.msireland.com/news/tysabri.html). See Table 2.2
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for a complete list o f drugs used. MS is big business as it has cost the Irish 
taxpayer from June 2002 to June 2003 €2,132,496 to supply drugs to MS patients. 
(Source: General Medical Services Payments Board).
2.1.11 Prognosis
While there are definite types recognised, there is no typical MS and symptoms 
vaiy from individual to individual, therefore trying to generalise a specific 
prognosis is not possible. The course o f MS is unpredictable and varies 
considerably in individuals; however the majority o f  people with MS can usually 
expect to live up to 95% o f the normal life span (http://www.nationalms- 
society.org/sourcebook-prognosis.asp). The difficulty in diagnosing MS due to the 
multiplicity o f symptoms can be quite difficult for people with MS to come to 
terms with.
Most people with MS are mildly affected and can lead reasonably normal lives, 
although some can lose their sight, the ability to talk, or may be confined to a 
wheelchair (http://www.ninds.nih.gov/disorders/multiple_sclerosis/multiple_scle- 
rosis.htm#What is_the_prognosis). However, some people with MS, perhaps with 
the progressive-relapsing subtype can lose the ability to speak, see, walk, etc., and 
the severe unrelenting progression can lead to death within a few months to a year 
(Herndon, 2003). Death from the direct effects o f MS on the nervous system is not 
usual and is more likely from complications as a result o f the paralysis caused by 
demyelination (Matthews, McAlpines MS 1991).
2.1.12 Overview
For the estimated 2.5 million people spread across the five continents, often struck 
down in the prime o f their lives by MS, with its puzzling prevalence and 
geographic distribution, who have to live with the unpredictability o f attacks and 
remissions, diminished quality o f life, daily regime of drug dependency coupled 
with the unpleasant side effects, no concrete sign o f a cause being identified or 
any sign o f a cure on the horizon, this study can do nothing for them, However, 
for genetically susceptible individuals who have yet to develop the disease this 
study may offer some hope to them. I f  the original hypothesis which states “that 
Radon exposure before the age o f 15 years is postulated as a contributory cause in 
genetically susceptible individuals” . (Gilmore and Grennan, 2003 p i 57) is proven,
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it may go some way towards eliminating the suffering that MS brings. It is not a 
cure but it may be a preventative measure.
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Table 2.2 List of Drugs used in Treating Symptoms of MS
ABC Treatm ents
C ondition /Sym ptom G eneric Name Com m ents Brand
Nam e
M anufacturer
R elapsina-R em ittlna In te rfe ro n  Beta la 30 meg 
in tram uscular 
once per w eek  
self-in jection
Avonex Biogen
MS, Secondary  
Proaressive MS with  
relapses
4 4  meg
subcutaneous 3 
tim es per w eek  
self-in jection
Rebif A res-Serono
In te rfe ro n  Beta lb Subcutaneous  
self-in jection once 
every  tw o days
Betaseron Berlex
Betaferon Scherinq
Relapsing-Rem itting MS Glati ra m er A cetate 20m g
subcutaneous  
daily self-in jection
Copaxone Teva-M arion
C hem otherapeutic Agents
C ondition /S ym ptom Generic Nam e Com m ents Brand
Name
M anufacturer
¡Secondary Progressive 
MS, Worsening  
Relapsing-Rem itting MS
M itoxantrone In travenous every  
3 m onths for 
about 2 to  3 years
N ovantrone Im m u n ex
Corticosteroids and ACTH
C ondition /Sym ptom Generic Nam e Com m ents Brand
Nam e
M anufacturer
Acute relapses in 
Relapsing-Rem itting MS 
and occasionally 
Secondary Progressive 
MS
M ethylPrednisolone In travenous high 
doses tap ered  off
Depo-M edrol
Solu-M edrol Pharm acia
Prednisone Oral
adm inistration
Deltasone Pharmacia
Prednisolone In travenous
adm inistration
D e lta -C o rte f Pharmacia
Dexam ethasone Oral
adm inistration
Medrol Pharmacia
Decadron Merck
Adreno-corticotrophic  
H orm one (A CTH ), 
Corticotropin
Use largely  
replaced by 
synthetic  
corticosteroids
A cthar Roche. Rhone- 
Poulenc Rorer
P a in /A lte red  Sensation (D ysaesthes ia)
C ondition /Sym ptom G eneric Nam e Com m ents Brand
Nam e
M anufacturer
N europathic/neurogeni 
c pain (pain th a t arises 
from  nerve dysfunction  
and not as a result of 
injury e.g . Trigem inal
C arbam azeDine A nti-convulsant Tegreto l,
Epitol,
A tretol,
Carbatrol
Ciba
G abapentin  A nti-convulsant Neurontin Pfizer
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Neuralgia) Top iram ate  A nti-convulsant Topam ax O rtho-M cNeil
Zonisam ide Anti-convulsant Zonegran Elan
Phenytoin Dilantin
D esipram ine Norpramin
Amitriptyline Tricyclic
an tidepressant
Elavil A straZeneca
Imipramine Tricyclic
antidepressant
Tofranil. Ciba G eiav
Im a v a te ,
Janimine
Doxepin Tricyclic
an tidepressant
Sinequan,
Adapln,
Triadapln,
Zonalon
Protriptyline Tricyclic
antidepressant
Vivactil
Cannabis and 
synthetic cannablnoids
Illegal In many 
parts of the world
Marinol
Pain associated with 
poor circulation
Pentoxifylline Trental
'flu-like symptoms Ibprofen Neurofen
associated with Beta 
In terferon  injections
US versions
Aspirin generic
A cetam inophen O ften  formulated 
w ith alkaloid pain 
killers like codeine 
and hydrocodone
generic
Paroxysmal itching Hydroxyzine A tarax
D ep ress io n /A n x ie ty /In so m n ia
C ondition/Sym ptom Generic Name Com m ents Brand
Name
M anufacturer
Depression without
anxiety
Fluoxetine S elective Prozac Eli Lillv
Serotonin
R euptake
In h ib ito rs
Mild anxiety, panic Sertraline Selective Zoloft Pfizer
attacks, people on Serotonin Lustral Pfizer
multiple medications Reuptake
In h ib ito rs
M oderate depression, 
anxiety, people for 
whom other 
antidepressants don't 
work
Venlafaxlne S elective
Serotonin
Effexor _x r W yeth -A yerst
Laboratories
R euptake
In h ib ito rs
Depression with mild
anxiety
C italopram S elective Celexa Forest
Serotonin Pharm aceuticals
Reuotake
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Inhibitors
Depression with mild 
anxiety
Parocetlne Selective
Serotonin
Reuptake
Inhibitors
Paxil,
Seroxat
Glaxo-Smith-Kline
Depression also 
agoraphobia, 
insomnia, essential 
tremor, some pain 
syndromes
Trazodone Similar to SSRIs - 
works by 
increasing the 
amount of 
serotonin
Desyrel,
Triaiodine
Pharmacia
Depression Amitriptyline Tricyclic
antidepressant
Elavil AstraZeneca
Endogenous
depression
Nortriptyline Tricyclic
antidepressant
Pamelor Novartis
Aventyl Eli Ullv
Depression Imipramine Tricyclic
antidepressant
Tofranil. Ciba Gelav
Imavate,
Janimine
Depression particularly 
when accompanied by 
anxiety and insomnia
Dothiepin Tricyclic
antidepressant
Prothiaden Knoll
Pharmaceuticals
Depression of varying 
severity with coexisting 
anxiety
Lofepramine Tricyclic
antidepressant
Gamanil Orqanon
Anxiety, neurosis, 
manic depression
Doxepin Tricyclic
antidepressant
Sinequan,
Adapin,
Triadapin,
Zonalon
All types of depression, 
apathety, withdrawal
Protriptyline Tricyclic
antidepressant
Vivactil
Moderate to severe 
depression
Tranylcypromine Monoamine 
oxidase inhibitor 
(MAOI)
Parnate Glaxo-Smith-Kline
Depression particularly 
when accompanied by 
social phobia
Moclobemide Monoamine 
oxidase inhibitor 
(MAOI)
Manerix,
Aurorix
Roche
Withdrawn, depression- 
related fatigue, 
concentration and 
attention problems, 
depression-related 
sexual dysfunction
BuDroDion Aminoketone
antidepressant
Wellbutrin Glaxo-Smith-Kline
SR
Amfebutamo
ne
Depression with 
significant anxiety, 
panic attacks, 
Insomnia, sexual 
dysfunction
Nefazodone Phenylpiperazine
antidepressant
Serzone Bristol-Mvers
Sauibb
Depression with 
insomnia, moderate to 
severe anxiety, sexual 
dysfunction
Mirtazapine Piperazino-
azepine
antidepressant
Remeron Organon
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Insomnia Zolpidem Imidazopyridine Ambien Pharmacia
Anxiety - not indicated 
if primary complaint is 
depression
Alprazolam Benzodiazepine - 
addictive
Xanax Pharmacia and
Upjohn
Insomnia, Anxiety Temazepam Benzodiazepine - 
addictive
Restorii Novartis
Anxiety, Insomnia, 
muscle relaxant
Diazepam Benzodiazepine - 
addictive
Valium Roche
Anxiety Buspirone Azaspirodecanedio
ne
BuSpar Bristol-Mvers
Squibb
Fatigue
C ondition /Sym ptom Generic Nam e Com m ents Brand
Name
M anufacturer
Multiple sclerosis 
fatlque. Also dystonia
Amantadine Anti-viral Symmetrel Endo
Pharmaceuticals
and akathisia
Fatigue Pemoline Central Nervous Cvlert
System stimulant
Modaflnll 1 Provigil
U rinary Problem s
C ondition /Sym ptom Generic Name Com m ents Brand
Name
M anufacturer
Urinary Frequency and 
Urgency
Oxybutynln Ditropan XL
Desmopressin,
Vasopressin
Nasal spray DDAVP
Urinary Urgency and 
Incontinence
Tolterodine Detrol
Carbamazepine Anti-convulsant Tegretol,
Epitol,
Atretol,
Carbatrol
Ciba
Imipramine Tofranil
Bethane Urecholine
Urinary Hestitancy Phenoxybenzamine Dibenzyline
Terazosin Hytrin
Spastic Bladder Propantheline Anticholinergic
agent
Pro-
Banthine
Oxybutynin Anticholinergic
agent
Ditropan
Hyoscyamine Anticholinergic
agent
Urispas
Cystopas
Baclofen Skeletal muscle Lioresal 
relaxant
Diazepam Benzodiazepine - Vallium 
addictive
Urinary Tract Infections 
(UTI)
Methenamine Hiprex
Mandelamine
Nitrofurantoin Macrodantin
Phenazopyridine |Pyridium
Ciprofloxacin Cipro
Bowel Problem s
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C ondition /Sym ptom Generic Name Com m ents Brand
Name
M anufacturer
Constipation Bisacodyl S tim ulan t Dulcolax
laxative Bisacolax
M agnesium  hydroxide  
(Milk of Magnesia)
Hyperosmotic
laxative
generic
Glycerin Hyperosm otic
laxative ,
suppository
Sani-Supp
Psyllium hydrophilic 
mucllloid
Bulk-form ing oral 
laxative
Metamucil
Sodium  phosphate Fleet Enem a
Docusate Stool S oftener Colace
Suppository Therevac
Plus
Sexual Dysfunction
C ondition /S ym ptom Generic Name Com m ents Brand
Name
M anufacturer
Erectile dysfunction In 
men and w om en
Sildenafil V iagra
Erectile dysfunction Alprostadil Suppository Prostin VR
MUSE
Papaverine In jection  into 
penis
S pastic ity /C lonus/M usc le  Tics
C ondition /S ym ptom Generic Nam e Com m ents Brand
Nam e
M anufacturer
Spasticity D iazepam Benzodiazepine Vallum
Clonazepam Benzodiazepine Klonopln
Rivotril
Baclofen S keletal muscle 
re laxant
Lioresal
Dantro lene sodium Skeletal muscle 
re laxant
Dantrium
Tlzanidlne ¡Skeletal muscle Zanaflex Elan
re laxant Slrdalud
Clonidine A ntihypertensive C atapres L _  :J
Botulinum  Toxin Kills Nerves Botox,
Neurobloc
Elan
Trem or
C ondition /Sym ptom Generic Nam e Com m ents Brand
Name
M anufacturer
Postural tremor Clonazepam Klonopin
Rivotril
G abapentin Neuronttn
Beta blockers
Primidone Mysoline
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Botulinum toxin Kills Nerves
Acetazolamlde Dlamox
Rest tremor Levodopaandshy; carbi 
dopa
S inem et
anticholinergics
Trem or Isoniazid Laniazld
Nydrazid
V ertigo , Nausea, D izziness
C ondition /Sym ptom Generic Name Com m ents Brand
Name
M anufacturer
Vertigo, Nausea, Meclizine A ntivert
Dizziness Bonamine
Dimenhydrinate Dramamine
Prochlorperazine Compazine
Scopolam ine Transderm
D iphenhydram ine r Benedryl
A nti-v ira ls /V acc in atio n s
C ondition /Sym ptom Generic Name Com m ents Brand
Name
M anufacturer
Prevention of Relapses 'flu jabs Now
recommended for 
people with MS
N /A N /A
Acyclovir
O ther T rea tm en ts /E xp e rim en ta l Medications
C ondition /Sym ptom Generic Name Com m ents Brand
Name
M anufacturer
RelasDSina-Remittina N atalizum ab Monoclonal A ntearen Elan/B ioaen
Multiple Sclerosis and 
possibly Secondary  
Proaressive MS
antibody -  blocks 
access for
the  central
nervous system
Relaspsina-Remittina A lem tuzum ab Monoclonal C a m p a th -IH Schering/MHIenniu
antibody -  kills T m
Secondary Proaressive Cells P harm aceuticals /IL
MS EX Oncoloav
4-a jn jnopyrid ine Blockspotassium  
channels in 
neurons which 
m ay im prove  
nerve
transm ission in 
MS
Fam pridine Elan/Accorda
3,4 Dlaminopyridine Blocks potassium  
channels in 
neurons which 
m ay im prove  
nerve
transm ission in 
MS
27
Eliprodil Might promote 
remyeiination
IV Immunoglobin Reduces severity 
of viral infections
Gammagard,
Gammar-IV,
Gamimune
N, Iveegam,
Panglobulin,
Sandoglobuli
n,
Venoglobulln
May reduce 
severity of 
relapses
AnergiX-MS Anergen
Neuropathic pain Pregaballn Concerns raised 
over safety 
because of 
tumours in mice
Pfizer
Chronic pain Ziconotide Non-opioid, 
calcium channel 
blocker
Elan/Neurex
Source: http://www.mult-sclerosis.org/mstreatments.htinl
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2.2 De s c r ip t io n  o f  R a d o n
2.2.1 What is Radon and Where does it come from?
Radon is a common, naturally occurring colourless, odourless, tasteless, 
radioactive noble gas. It is the heaviest noble gas, being nine times heavier than 
air and is soluble in water and fat (Gilmore and Grennan, 2003). It is created 
naturally by the breakdown of uranium and radium (table 2.3) and is continuously 
released from rocks and soil containing these two elements (Nazaroff and Nero, 
1988) and (O’Dea 1997).
Table 2.3 Uranium-238 Decay Chain
Sym bol Elem ent R a d ia tio n H a lf -L if e D e ca y  P ro d u ct
U -2 3 8
1
U ranium -238 alpha 4,460,000,000 years T h -2 3 4
T h -2 3 4 Thorium -234 beta 2 4 .1  days P a-234
P a -234 Protactinium -234 beta 1 . 1 7  minutes U -2 3 4
U -2 3 4 U ranium -234 alpha 247,000 years T h -2 3 0
T h -2 3 0 Thorium -230 alpha 80,000 years R a -2 2 6
R a -22 6 Radium -226 alpha 1,6 0 2  years R n -2 2 2
R n -2 2 2 R adon-222 alpha 3.82 days P o -2 18
P o -2 18 Po lo n ium -218 alpha 3.05 minutes P b -2 14
P b -2 14 L e a d -2 14 beta 2 7  minutes B i-2 1 4
B i-2 1 4 B ism u th -214 beta 19 .7  minutes P o -2 14
P o -2 14 P o lo n iu m -214 alpha 1 microsecond P b -2 10
P b -2 10 L e a d -2 10 beta 2 2.3  years B i-2 1 0
B i-2 1 0 B ism u th -210 beta 5 .0 1 days P o -2 10
P o -2 10 Po lo n ium -210 alpha 138 .4  days Pb-206
Pb-206 Lead-206 none stable (none)
Source: New York State Department of Health
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Uranium and radium may be found in almost all soil and rock, but are most often 
associated with those containing granite, shale and phosphate. Soil gas represents 
the predominant source o f indoor Radon and the main site for Radon exposure is 
the home (Field, 1999). In a study by Nicholls (1999) it was noted that the high 
indoor radon levels were discovered to be associated with limestone, shale and 
sandstone as well as a variety o f  clays. It is emitted from all ice-free land surfaces. 
Ice cover inhibits its emissions (Conen, 2003).
Radon spontaneously decays to produce Radon progeny (daughters) and it is these 
progeny, rather than the Radon itself, which are responsible for the adverse health 
effects o f indoor Radon exposure. These progeny are minute solid particles (alpha 
particles) and can adhere to dust particles in the air (O’Dea, 1997).
The rate at which a radioactive element decays is known as its half life, i.e., the 
time taken for half o f a radioactive element in a sample to decay into another 
element. Radon has a half-life o f 3.8 days and its progeny have a half-life o f about 
30 minutes (Nazaroff and Nero, 1988).
The amount o f Radon in air is measured in Becquerels per cubic metre (Bq/m3). 
One Becquerel (Bq) represents one radioactive disintegration, (a nucleus giving 
off a ray or particle) per second. Outdoors, Radon is not a problem as it dissipates 
and is considered harmless. It is estimated that every square mile o f soil to a depth 
o f 6 inches contains about lg  o f  radium, which releases Radon in tiny amounts 
into the atmosphere (http://ww-w.scescape.net/~woods/elements/general).
The discovery o f Radon has been credited to Fredrich Ernst Dorn who called it
“radium emanation” circa 1898. By 1908 it had been renamed “niton” by Ramsay 
and Gray, who isolated the element and determined its density. Since 1923 it has 
been called Radon. Since its discovery, many uses have been found for Radon, 
one o f the first being as a supposed therapeutic aid. Many people believed that 
inhaling Radon had beneficial effects. Some towns, e.g. Hot Springs, Arkansas, 
USA, attracted many tourists on the strength o f the Radon in its thermal waters. 
As more has become known about Radon, so the potential uses o f it in geological 
and environmental applications have grown. Some o f its uses include; monitoring
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atmospheric mixing, investigating monsoon circulation patterns, predicting 
earthquakes and volcanic eruptions and mapping geological faults 
(http ://www. geol-soc. org.uk/pdfs/Radon. pdf).
2.2.2 Is it Dangerous to Humans?
The link between Radon (although not officially discovered until circa 1898), and 
lung cancer was first postulated, as early as 1556 by Georgius Agricola (1494 -  
1555) (Field, 1999). He described high mortality rates from respiratory diseases 
among underground metal miners as “an angel choking old miners to death” 
(Weber, 2002), at Schneeberg in the Erz Mountains o f  Central Europe. Harting 
and Hesse in 1879, based their finding on post-mortems which showed pulmonary 
malignancies as being the cause o f the high mortality rates at Schneeberg 
(Commission on Life Sciences 1999), in 1921 Uhlig proposed that radium 
emanation might be the cause o f the lung cancers (Field 1999). In 1939 Peller first 
reviewed and described mining related cancers, in Schneeberg and Joachimsthal 
miners, and finally, in the mid 1950s 222Rn progeny inhalation rather than 
222Radon gas was cited as the causative agent in the excessive lung cancer deaths 
for miners in both the United States and Europe (Field, 1999). There is little 
disagreement that breathing air containing Radon caused thousands o f  uranium 
miners to get lung cancer. The known ill-health effects from Radon exposure 
include lung cancer from breathing the gas and a significant risk o f stomach 
cancer from drinking Radon contaminated water (Kendall and Smith, 2002).
2.2.3 Radon and Lung Cancer
Radon decay products attach to dust particles present in air. The particle is then 
inhaled into the lungs where it lodges. Once in the lungs, these decay products 
deliver a small burst o f  radioactive energy. These emissions o f energy are the 
source o f lung cancer caused by Radon decay products. As these progeny are 
radioactive and have half-lives o f less than 30 mins there is the likelihood that 
before they can be cleared from the lung that the deposition o f 210Pb by decay, on 
the lining o f the lung will occur (Nazaroff and Nero, 1988). Information gleaned 
from the American Association o f Radon Scientists and Technologists shows that 
the “average person in the U.S. gets more radiation dose from exposure to indoor
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Radon than from any other source o f natural or man-made radiation” (Radon 
Risks and Health Effects 1987), (See Fig. 2.8).
There is an abundance o f literature e.g. BEIR VI published by the Commission on 
Life Sciences 1999, that implicates Radon as a causative agent in the contraction 
o f lung cancer. It cannot be proven without an unethical trial, but there is little 
doubt that exposure to excessive amounts o f Radon will cause lung cancer in 
susceptible individuals. Experimental animal studies show higher rates o f lung 
tumours among rodents exposed to high Radon levels (Cancer Facts -  National 
Cancer Institute 2004). Kendall and Smith (2002) suggested that exposure to 
Radon could lead to  increased risk o f  lung cancer. Barros-Dios, Barreiro, Ruano- 
Ravina and Figueiras, (2002) in their study suggest that, even at concentrations far 
below official guideline levels, that exposure to Radon may lead to  a 2.5 fold rise 
in the risk o f lung cancer. Furthermore, they also point to more recent case control 
studies in locations as far apart as Sweden, Moscow, Germany, England, Missouri 
and Iowa, that seem to  add greater support for the idea that there is an association 
between Radon and lung cancer. In the Iowa lung cancer study carried out by 
Field, Steck, Smith, Brus, Fisher, Neuberger, Platz, Robinson, Woolson and 
Lynch, (2000) it was suggested that Radon exposure is a significant risk factor for 
lung cancer in women. The UK Radiological Protection Board concluded, because 
o f higher than expected concentrations o f Radon in houses in a study entitled 
“Radon and Health” that Radon is more dangerous than has previously been 
thought (Bowie and Bowie, 1991).
2.2.4 Radon and Water
Radon, being soluble in water can also be considered a health risk and it is 
considered the second most important source o f indoor radon (http://wwwl.umn.- 
edu/eoh/hazards/haz-ardssite/radon/radonintro.html). In some areas depending on 
local geology, it dissolves, often in high concentrations in ground water. These 
concentrations will be higher if the groundwater is in contact with uranium 
bearing rock. Ground water is more likely to  have high levels o f Radon than 
surface water, i.e., streams, rivers, lakes. The more water is agitated the lower the 
Radon concentrations are. Therefore, households that use private water sources,
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e.g. wells are more likely to be exposed to large amounts o f Radon, and this may 
be either ingested or inhaled.
The main risk from Radon in water comes from breathing Radon released to 
indoor air from household water uses. American EPA studies concur (US EPA, 
2003) as their greatest concern about Radon in water is not from ingestion, but 
from the release o f Radon into the air, during normal household water uses. 
However, if such water is ingested, the Radon remains in the stomach from where 
it is passed to the small intestine and from there to the blood (Kendall and Smith, 
2002).
Kohli, Noorlind Brage and Lofman, (2000) in their study o f childhood leukaemia 
and Radon, cite a US study that found the association between groundwater 
Radon concentration and overall cancer mortality in children under 15, was the 
strongest for leukaemia.
There seems to be little direct information relating to cancer o f the stomach from 
ingesting Radon enriched water, though Kjellberg and Wiseman (1995) observed 
in an ecological study set in Pennsylvania a correlation between stomach cancer 
and Radon levels, cited in (Kendall and Smith, 2002).
2.2.5 Other Adverse Effects of Radon Exposure
2.2.5.1 Radon and Other Cancers
According to the World Health Organisation, Radon is classified as a Class A 
known human carcinogen; however, with indoor Radon, the levels o f Radon 
present in the air and the length o f time one is exposed to it are important factors 
to be borne in mind.
In a study carried out by the American Academy o f Paediatrics (1989) entitled 
“Radon Exposure -  A Hazard to Children” it is considered plausible that exposure 
before the age o f 20 might have greater effects than exposure at later ages. This 
hypothesis was derived at by studying the evidence o f Japanese atomic bomb 
survivors who were exposed to radiation before the age o f 20. It was found that
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they had higher relative risks o f developing radiation-induced cancers than those 
exposed later in life.
Several studies mentioned in a study by Kohli et al. (2000) confirm an association 
between Radon and malignancies. They postulated that there is a relationship 
between the incidence o f Acute Lymphatic Leukaemia (ALL) in children and 
exposure to radiation from background Radon. They also saw a stronger 
association between incidence o f leukaemia and remaining in high-risk areas than 
the risk level at place o f birth they concluded that children are less likely to 
develop ALL if they are born in and stay in areas where the risk from ground 
Radon has been classified as low than if they are bom  in and stay in areas that are 
deemed to be normal to high risk areas. This can also be said o f MS. There is 
epidemiological evidence which shows that moving from an area o f low/high MS 
prevalence after the age o f 15, the risk o f  developing MS is as for the area moved 
from (Dean and Elian, 1997). This will be expanded on later.
A study carried out by Etherington, Pheby and Bray, (1996) entitled “An 
ecological study o f cancer incidence and Radon levels in South West England” 
reported a correlation between Radon levels and non-melanoma skin cancer. 
There seems to little doubt that exposure to Radon and its daughters have adverse 
health effects.
2.2.5.2 Radon and Fat
Another characteristic o f Radon is its solubility in fat. In animal studies, Radon 
was shown to be highly soluble, in fact reaching concentration levels five times 
that o f the atmosphere within 24 hours (Bowie and Bowie, 1991). Fat receives the 
highest dose o f all tissues except the lung (Kendall and Smith, 2002), because 
Radon is more soluble in fat than in other tissues, including blood. Radon 
permeates cell membranes with ease, including endothelial cells o f capillary 
walls. Blood transport around the body takes approximately one minute, thereby 
distributing Radon throughout the body. The fat content in tissues then governs 
radon concentration. Red bone marrow has a reasonably high fat content as does 
the female breast and consequently, both receive a high dose o f alpha radiation 
from the decay products o f Radon (Kendall and Smith, 2002). Myelin, the
34
substance that coats the nerves and the target for destruction in Multiple Sclerosis, 
is a fatty substance and therefore its reaction to Radon exposure should not be 
underestimated.
If  the bone marrow is harmed by exposure to alpha radiation, and studies by Zhou, 
Suzuki, Randers-Pehrson, Vannais, Chen, Trosko, Waldren and Hei, (2001 p. 
1415), show “clear evidence that a single alpha particle can induce mutations, and 
chromosome aberrations in cells that received no direct radiation exposure to their 
DNA”. Therefore, this provides clear evidence that “irradiation can induce a huge 
bystander mutagenic response in neighbouring cells not directly traversed by 
alpha particles” (Zhou et al. 2001 p. 1415). Therefore, the myelin damage, the 
cause o f the symptoms o f multiple sclerosis, has to be considered, given that stem 
cells come from bone marrow which may or may not have been damaged by 
exposure to alpha radiation from a very early age, perhaps even prior to birth. 
Recent studies by Wilier, Dyment, Sadovnick, Rothwell, Murray and Ebers, 
(2005) agree with other studies in twins and half siblings which suggest that the 
neonatal and/or the gestational environment influence the risk o f MS in later life.
2.2.5.3 Radon and Buildings
People typically spend more time indoors in winter and therefore are likely to be 
exposed to higher concentrations o f Radon that at other times o f the year. With 
modem building methods and home improvements throughout the years, homes 
have become more sealed than ever before. This leads to less home air exchanges 
per hour and consequently more exposure to Radon. Radon being nine times 
heavier than air will also be more concentrated at ground floor levels (Gilmore 
and Grennan, 2003).
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Fig. 2.6 How Radon enters Buildings
Source: (Geological Society o f London, July 2001).
Radon enters buildings because the air pressure inside buildings is slightly lower
than in the ground and they can draw in radon gas from several feet away. Stoves,
hot water heaters and fireplaces, reduce the pressure indoors. Warm air inside 
buildings moves upwards similar to a chimney and this reduces the indoor air 
pressure. Wind creates a vacuum on the downwind side by the Bernoulli effect. 
When the ground is frozen or soaked by rain, the radon in the ground moves to the 
warm and permeable gravel and disturbed ground underneath the house. The 
resulting advection (pressure driven flow) draws in radon through openings or 
cracks and through the pores in concrete. Radon is also pulled in by diffusion as it 
tries to equalise the indoor concentration (Commission on Life Sciences, 1999).
Approximately 18,000,000 homes across the United States have been tested for 
Radon (Gregory and Jalbert 2003), and of these, almost 800,000 have had 
remedial measure taken to reduce the occupants’ exposure to Radon. In Ireland 
11,319 homes have been tested by the Radiological Protection Institute of Ireland
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in their National Radon Survey. County Sligo had the largest amount o f high 
radon houses where 20% o f the houses exceeded the Reference Level.
The contradictory literature on Radon, where on the one hand Radon is being 
cited as being dangerous to health, and on the other, where in places like 
Germany, Austria, and the USA, people flock in their thousands to Radon spas for 
medical purposes every year is quite interesting. They go seeking miracle cures 
for diseases such as rheumatoid arthritis, multiple sclerosis, cataracts, depression, 
to name but a few (Erickson, date unknown). This only goes to show that much 
more work needs to be carried out on assessing the true nature o f Radon and its 
effects on human health.
The growing concern for Radon related illness continues. Recently in the 
Castleisland area o f Co. Kerry where one o f Europe’s most radioactive homes is, 
both the residents in this home lost their battle against lung cancer. Neither o f 
them were smokers. One o f the residents was in her mid 40’s and her husband was 
54. Last year the RPII wrote to 2,500 homes, urging them to have their homes 
tested. A mere 16% o f householders had their homes tested. Nine people have 
died o f cancer along a mile stretch o f road near this home, many o f them young 
(O’Connor 2004).
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So u r c e s  o f  E x po su r e  t o  R a d ia t io n
Cosmic rays (8%) 
(Outer space)
Internal (11%) 
(Inside our bodies)
Rocks and soil (8%) 
Medical X-rays (11%)
Nuclear medicine
Consumer products (3%)
'------------Nuclear fuel cycle (0.1%)
(03%) X------  Other (<1%)
Fig. 2.7 Sources o f Exposure
Source: Bums, FUNDAMENTALS OF CHEMISTRY 4/E, (c)2002, p.551. 
Reprinted by permission of Pearson Education, Inc., Upper Saddle River, New 
Jersey.
3. M e t h o d o l o g y
3.1 Summary
Following an extensive literature review, data was gathered directly from 
MS patients, via a questionnaire, distributed with MS News, which is the 
quarterly magazine o f the Multiple Sclerosis Society o f  Ireland. Its purpose 
is to provide a forum whereby news and views relating to MS can be 
discussed. The questionnaire was designed to establish the environmental 
milieu o f MS patients during the first fifteen years o f their lives. The 
information provided would be used, in conjunction with information 
supplied by the Radiological Protection Institute o f Ireland (RPII) to either 
refute or confirm that exposure to indoor Radon is potentially one o f the 
environmental agents that triggers the onset o f MS. The childhood home 
addresses o f MS patients were mapped and the results overlaid onto the map 
o f Ireland, detailing Radon distribution which was produced by the RPII. 
This data was then entered into an SPSS database for analysis.
3.2 Questionnaire Design and Piloting
The small-scale study, (Gilmore and Grennan, 2003) via a questionnaire 
survey, o f users o f the NW MS Therapy Centre, was studied and analysed. 
A new questionnaire was designed. Colleagues in the Dept, o f Public Health 
NWHB, provided some professional advice on this aspect o f the project. 
The resulting questionnaire was sent to twenty known MS patients for 
testing. No apparent problems arose with the questionnaire. It was 
considered feasible to proceed with the larger study designed to ascertain 
the true picture o f the distribution o f MS in Ireland.
3.3 M S  S o c i e t y  -  I r e l a n d  a n d  R e g i o n a l  O f f i c e s
Dr. Margaret Gilmore and Mr. Eamonn Grennan had built up a working 
relationship with the CEO o f MS Ireland, Mr. Michael Dineen over the 
years. This made the author’s task less onerous, as there was no cold- 
calling. The MS Society and regional offices were written to in early 
December 2002, informing them o f the current project. (Appendix 4). The 
author had regularly visited the MS Ireland website, with a view to finding
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out as much as possible about current research into MS in Ireland and 
general MS facts. This turned out to be one o f  the more fruitful contacts 
cultivated during the completion this project, for without their help, the 
project could have floundered. There followed several meetings with Mr. 
Dineen, culminating in an invitation to attend the Pringle Lecture in UCD 
and an agreement to distribute the questionnaire, see para 3.7.
3.4 Pringle Lecture
Dr. Robert Pringle (R.I.P) was the founder o f the Multiple Sclerosis Society 
o f Ireland and was among those responsible for the development o f the 
International Federation o f MS Societies. The theme of the lecture was 
“epidemiological studies and a statistical analysis o f MS in various 
countries”, and was delivered by the renowned neurologist, Prof. Geoffrey 
Dean on October 16th 2003. His lecture examined the history o f MS and he 
spoke about his research and findings in South Africa, Malta, Sicily and 
Ireland to name but a few.
His continued research showed that no Maltese people had ever been 
diagnosed with MS in the UK. This led him to Malta where he found that 
MS was very rare, finding only 16 patients. He believes that is due to 
genetics as Malta differs from the rest o f Europe in that it has a history o f 
settlement o f people from North Africa. On the contrary, his studies in 
Sicily which is only approximately 60 miles away, found high prevalence 
rates for MS, and even higher for Sardinia and the rest o f Italy. He also 
carried out studies in Cyprus and Spain.
The lecture finished with a question and answer session. Overall this lecture 
was most informative and the information gathered has been beneficial to 
this project. It was also a privilege to meet Prof. Dean and to have a chance 
to talk informally with him before the lecture.
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3.5 Neurologists
The first challenge was to access MS patients. The country’s neurologists 
were considered the best route to these. Fifteen neurologists were identified 
and located using the Irish Medical Directory and written to in December 
2002 (Appendix 1). They were informed o f the study and their cooperation 
was requested.
Eight replies were received. O f these, three would consider helping, one had 
retired and the other four had ethical concerns. Below are extracts from the 
replies.
“Any potential research project would have to go through the ethics 
committee. I t otherwise would not be possible to be involved with 
this project”.
“There would be major ethical concerns about releasing any 
information pertaining to patients. -  The other possibility would be 
to contact the M S Society”.
“M ost o f our information was obtained from  the local organisers 
both in Wexford and Donegal and I  would suggest that this might be 
the best route fo r  yo u ”.
“I  actually fe e l that you would be better served by approaching the 
M S Society”.
“I  would be grateful i f  you could send me the p ilo t study and after 
reading that I  might be willing to help ”.
“I  fin d  your research project o f great interest. Perhaps at some 
stage you might like to present your data at our Dublin 
Neuroscience meeting”, also pointing out that “I  have discussed
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your project with the ethics committee and you would need to apply 
form ally fo r  access to patient information ”.
“1 think this is certainly an interesting project and would be happy 
to cooperate in any way I  can, however I  am not at liberty to divulge 
any demographic information without the written consent o f the 
patients and consent o f the Health Board”.
An invitation to present the data, i.e. the data from the small-scale study 
mentioned in para 3.2, to the Dublin Neuroscience Meeting was accepted. 
This was arranged for the 28th March 2003. The presentation (Appendix 2) 
was well received.
There were follow up meetings with neurologists in St. James’ Hospital and 
the Beaumont Hospital, both in Dublin. Again, the ethics question came up 
and it was acknowledged to be an important obstacle. Even though the 
author felt that no ethical guidelines were being breached, the neurologists 
had some very understandable reservations about becoming involved in the 
study. The various ethical committees were identified and two applications 
were made. However, it was concluded by author and supervisors that this 
process was far too cumbersome for what the project was aiming at.
Having considered this route it was concluded
1) That such a route would be too cumbersome, albeit for very
good reasons
2) It was too complicated and
3) That it would take a long time to complete
4) That a successful outcome was not guaranteed, and
5) Since only about one third o f neurologists had indicated
support, the eventual survey might not be fully
representative.
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3.6 G e n e r a l  P r a c t i t i o n e r s  a n d  L o c a l  M e d i c a l  S t a f f  a n d  L i s t s
A team from St. Vincent’s University Hospital had just completed a study of 
MS prevalence in Counties Wexford and Donegal (McGuigan, et al. 2004). 
Having accessed this via the researchers, it was decided, for ascertaining the 
prevalence rates for the country as a whole, that some o f the methods 
employed were worth replicating. The method used to access the target 
audience included communications with General Practitioners, 
Neurologists, County Physicians, Hospital Coding Lists, Local MS 
Societies, Respite Care Facilities and Interferon Prescription Lists.
Having approached the neurologists and failed due to ethical considerations, 
the author thought that the General Practitioners would be a worthy 
alternative. Having discovered that there are approximately 1,500 practices 
in the country (plus private ones) and given the previous responses plus the 
cost and practicalities involved in writing to all o f these, the author decided 
that this course o f action would be too onerous and unlikely to yield a 
positive outcome. County Physicians and Hospital Coding Lists were also 
considered to be avenues that would entail more hurdles than could be dealt 
with, e.g., ethical committees. That left the MS Society, Respite Care 
Facilities and Interferon Prescription Lists. Having had the co-operation 
from the MS Society, it was decided that this would be the best route for the 
success o f this project. Information was also obtained from the GMS (P) 
Board and this will be revisited.
3.7 Q u e s t i o n n a i r e  D i s t r i b u t i o n
One o f the outcomes o f the meetings with the CEO MS Ireland, was an 
agreement whereby the MS Society Ireland consented to distribute the 
questionnaire with their magazine “MS News” in Jan 2004. Addressed 
envelopes were included, to aid responses. It was agreed following 
discussions with MS Ireland staff and other polling bodies, that there was no 
need to include stamped envelopes. Furthermore, the impression o f the staff 
o f MS Ireland is, that the membership are quite good about taking part in 
surveys and this proved to be correct. No prior knowledge o f where, or to
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whom the questionnaires were going to was made available, nor was it 
sought. The only information sought was the number by county of 
subscribers to MS News. This would help to work out the response rate by 
county, rather than the overall response rate, thereby helping to give a more 
accurate picture. The CEO also suggested that an accompanying article, 
explaining the rationale for the research project (Appendix 5) should be 
included. However, unfortunately the article was inadvertently omitted from 
the magazine. This may have contributed to the lower than expected 
response rate, but nevertheless it should be emphasised that the response 
rate was still very satisfactory.
3.8 Radiological Protection institute Ireland (RPII)
The RPH carried out a survey between 1992 and 1999 to identify the areas 
most at risk from elevated indoor Radon levels. (See table 3.1) It was a 
geographically based survey using the 10km grid squares o f the Irish 
National Grid. Based on statistical advice, it was determined that a 
minimum o f five samples was required from each 10km grid square to make 
valid predictions. Measurements were carried out for 12 months and the 
results were used to predict the percentage o f dwellings for each grid square 
that exceeded the (safe?) reference level o f 200 Bq/m3. Therefore, if  more 
than 10% o f dwellings in any given grid square are predicted to have Radon 
levels above the reference level, then that grid square is considered a high 
Radon area and coloured light brown, or dark brown (Fennell, Mackin, 
Madden, McGarry, Dufly, O ’Colmain, Colgan, and Pollard, 2002)
“For squares in which there were fewer than five valid measurement results 
the Geometric Mean and Geometric Standard Deviation were estimated 
from data in the surrounding squares. A smoothing algorithm, optimised on 
the Irish data set using the cp-criterion, was used” (Fennell, et al. 2002 
p.40).
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i^/g. 3.1 Map o f Ireland showing the valid number o f measurements o f 
Radon in dwellings per lOKm grid square. (Source: R P II2002)
There are 837 grid squares covering the Republic o f Ireland and fig 3.1 
shows the number o f valid measurements per lOKm grid square. These 
measurements were taken in domestic dwellings to predict the percentage o f 
dwellings that are likely to exceed the reference level. O f these 837 grid
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squares 28% (n = 234 have been classified as being High Radon Areas. The 
counties that stand out are, Carlow, Kilkenny, Waterford, Wexford and 
Wicklow, and in the west the counties that stand out are Clare, Galway, 
Mayo and Sligo (Fennell, et al. 2002) (See fig 4.6)
Table 3 .1 Summary o f Results by County. (Source:RPII 2002)
C ou n ty
N o . o f  
D w ellin g s  
M easu red
N o . > 2 0 0 B q /m 3 
(%  o f  d w ellin gs  
m easured
M ea n (B q /m 3)
M ax
(B q /m 3)
Carlow 194 30 (15% ) 123 1562
Cavan 180 5 (3%) 67 780
Clare 742 66 (9%) 88 1489
Cork 1211 71 (6%) 76 1502
Donegal 487 18 (4%) 69 512
Dublin 155 6 (4%) 73 260
Galway 1213 181 (4%) 112 1881
Kerry 932 52 (6%) 70 1924
Kildare 480 29  (6%) 90 1114
Kilkenny 181 16 (9%) 100 717
Laois 334 17 (5%) 83 565
Leitrim 145 6 (5%) 60 433
Limerick 524 41 (8%) 77 1102
Longford 132 8 (6%) 75 450
Louth 124 14(11% ) 112 751
M ayo 1184 152 (13%) 100 1214
M eath 233 18 (8%) 102 671
Monaghan 120 4 (3%) 68 365
Offaly 286 7 (2%) 68 195
Roscommon 235 17 (7%) 91 1387
Sligo 270 54 (20%) 145 969
Tipperary 852 63 (7%) 79 1318
Waterford 162 20 (12%) 119 1359
W estmeath 289 20 (7%) 91 699
W exford 469 54 (12%) 99 1124
W icklow 185 24 (13%) 131 1032
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The RPII provided an up to  date Radon Map o f Ireland and gave permission 
to use their map in whatever way was deemed suitable. They provided the 
information that enabled the coding o f their radon map o f Ireland into 5% 
intervals. They also provided on CD their Radon map o f Ireland that was 
required by Dr. Dennis Pringle, Dept o f Geography, NUI, Maynooth, to plot 
the cases o f MS.
3.9 National Cancer Registry
Data was obtained on lung cancer from the National Cancer Registry. As 
mentioned previously, Radon is known to cause lung cancer. The high 
Radon areas are known, but whether or not the lung cancer patients were 
smokers, and data on how much time they spent in a particular area/home, 
was not available. However, the data gleaned from this source provided 
some interesting and possibly comparable figures.
3.10 Health Boards
The Health Boards and the National Physical and Sensory Disability 
Database were contacted. It should be pointed out that that not everyone 
with a disability will be included in the database, as inclusion is voluntary. It 
was also pointed out that quite often people with MS do not like to advertise 
their condition. Furthermore, when a person reaches sixty-five, they are 
removed from the database. Also, the database in each Health Board area is 
incomplete, at the time o f writing. This appears to be a serious deficiency 
worthy o f further consideration. This line o f enquiry was closed.
3.11 Drug Companies
Schering AG who produce Betaferon, were contacted with a view to 
obtaining prescribing patterns for Ireland. One o f their representatives 
informed the author that Schering AG produce only one of the four products 
used in the treatment o f MS. Furthermore, he also intimated that the 
information sought was commercially and ethically sensitive and felt that it 
could not made public. Similar responses were received from Serona who
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produce Rebif, and from Biogen who produce Avonex. Yet again, a cul-de-
sac.
3.12 GMS(P) Board
The GMS payments board were contacted and they sent a breakdown by 
county, gender and age o f the numbers o f patients being prescribed 
interferon (Appendix 6). As this is the main drug used for treating the 
symptoms of MS, this information was used to compare drug use with MS 
distribution rates. This data will be presented and discussed later.
3.13 D e p t  o f  G e o g r a p h y  -  NUI M a y n o o t h
An outline o f the project and presentation o f the preliminary results was 
given at the 10th annual ENRGHI conference in June 2004. Great interest in 
the project was shown at this conference and some interesting contacts were 
made. These contacts have turned out to be very worthwhile, as they were 
helpful in plotting the cases o f MS on to the Radon map o f Ireland. The 
technology needed to do this is not available at IT Sligo.
3.14 M u l t i p l e  S c l e r o s i s  I n t e r n a t i o n a l  F e d e r a t i o n  (MSIF)
The author subscribes to “World o f  MS Update Service” and weekly reports 
are posted via email, with details o f the latest research into MS. This site has 
been very informative and has provided an insight into the scale o f research 
that has been and is currently being undertaken throughout the world. To 
date no notification o f any research similar to this work has been reported.
3.15 A n a l y s i s  o f  Q u e s t i o n n a i r e
A total o f 671 responses have been received and the data has been entered 
into an SPSS database. Excel is also being used as a tool for analysis and 
presentation o f data. Ongoing assistance from experts in this field is being 
received and is acknowledged elsewhere.
The address data provided on the questionnaires has been geocoded by 
Gamma Ltd., Dublin. Geocoding is a process whereby addresses are
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assigned map co-ordinates (Eastings and Northings). This method was used 
as it was considered too onerous to manually plot 671 addresses, plus 87 
second home addresses. However, Co. Donegal was manually done to cross- 
reference data from Gamma Ltd., and the results were the same. The 
geocoded data was sent for plotting to Dr. Pringle o f  NUI Maynooth. Dr. 
Pringle has made the computer software and expertise for plotting the cases 
o f MS available (Fig 4.5). The author also plotted the geocoded data 
manually (Fig 4.6). This geocoded data has been added to the database 
along with codes for each lOKm grid square on the map o f Ireland on which 
the Radon data has also been plotted.
An inconsistency on this map was identified (Grennan, pers comm.) and 
data to rectify it was supplied by RPII. It was that the grid squares were 
colour coded depending on their radon readings, e.g. <1% (of houses 
containing Radon levels above 200Bq/m3), 1-5%, 5-10%, 10-20% and 
>20%. The ratings increase in increments o f 5% except for the 10-20%, 
which is obviously an increment o f  10%. Based on information supplied 
from RPH this inconsistency was circumvented and the information 
provided enabled the subdivision o f  the 10-20% grid squares. Therefore, the 
coding system used is based on six divisions numbered 1 -  6, 1 being the 
lowest Radon reading and 6 being the highest.
3.16 Conclusion
The road from questionnaire design to final analysis was fraught with 
obstacles, which at times were seen as almost insurmountable. However, 
each problem was considered a challenge, and each challenge met with 
tenacity. As mentioned previously, this project could have floundered had it 
not been for the good offices o f the many people that were befriended 
during the preparatory stages o f the project. The willingness o f the many 
over the insouciance o f the few were what kept the project rolling on to the 
stage o f finality that it has now reached. One o f the objectives that will not 
be met, and for the author is regrettable, is that the overall prevalence rate 
for MS in Ireland is still unknown.
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4. Re su l t s
4.1 Response Rate
The questionnaire was distributed with MS News to  5,342 members. (Table 4.1 
shows distribution and response rate by County). O f these approximately 3,000 
have been diagnosed with MS (source: MS Ireland 2004, pers. comm.), which 
represents approximately 56% o f readership o f MS News. From this 56% or 
3,000, 671 responses were received. This represents a response rate o f over 22%. 
For statistical inference, a higher response rate would have been desirable.
4.1.1 Response by County
The county with the highest response rate was Clare with a response rate o f 32.8% 
and the lowest was Carlow at just 3.5%. Analysing by county will enable a more 
detailed comparison between counties with high and or low radon levels and give 
a more accurate reading o f the true picture o f MS. O f the 671 responses, 56 were 
excluded in this section as the county o f origin could not be established, or they 
were from outside the 26 counties. Data by county was therefore analysed for 615 
respondents as per table 4.1.
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Fig. 4.1 Response Rate by County
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Table 4.1 Distribution and Response Rate by County
County Q’s Distributed
No of 
Responses
%
Response
Rate
Carlow 139 5 3.5
Cavan 78 15 19.2
Clare 64 21 32.8
Cork 423 73 17.3
Donegal 186 38 20.4
Dublin 797 122 15.3
Galway 480 31 6.4
Kerry 380 23 6.0
Kildare 181 13 7.1
Kilkenny 83 18 21.6
Laois 179 11 6.1
Leitrim 98 14 14.2
Limerick 469 28 5.9
Longford 86 7 8.1
Louth 101 11 10.8
Mayo 139 43 30.0
Meath 148 16 10.8
Monaghan 193 18 9.3
Offaly 85 7 8.2
Roscommon 195 13 6.6
Sligo 156 20 12.8
Tipp 193 16 8.2
Waterford 186 11 5.9
Westmeath 83 8 9.6
Wexford 97 17 17.5
Wicklow 123 16 13.0
Total 5342 615
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Cases by Questionnaire Distributed
4.2 D i s t r i b u t i o n  o f  MS b y  C o u n t y
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Kilkenny 
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Limerick 1 
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Sligo 1 
Tipperary 
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Westmeath 
Wexford 
Wicklow
No. of Respondents
Fig. 4.2 Distribution o f Respondents by County
As expected, the majority o f responses came from Dublin (n = 122), followed by 
Cork (n = 73) and this mirrors population statistics. I f  the number o f responses 
were to mirror population statistics throughout Ireland, the third highest response 
rate should be from Galway, but Mayo comes third with (n = 43) responses, even 
though it ranks 10th in size o f population. Donegal had the fourth highest response 
rate with (n = 38) responses and it ranks 7th by population. Interestingly, Kildare 
which ranks 5th in terms o f population, had a low response rate (n = 13), joint 
eighteenth. It also has relatively low radon levels. Table 4.2 below shows the 
counties ranked by population and by number o f  responses. I f  there were an even 
distribution of MS throughout the country, one would expect to see similarities 
between response rate and population size. The contrasting data is perhaps 
indicative o f  the uneven distribution o f MS throughout the country.
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Table 4.2 Counties by Population and Number of Responses
Ranked by 
population County
Ranked by number of 
response
1st 1,122,821 Dublin 1st
2nd 447,829 Cork 2nd
3rd 209,077 Galway 5th
4th 175,304 Limerick 6th
5* 163,994 Kildare Joint 18th
6th 140,131 Tipperary Joint 13th
7th 137,575 Donegal 4th
8th 134,005 Meath Joint 13th
gth 132,527 Kerry *jth
lO* 117,446 Mayo 3rd
11* 116,596 Wexford 12th
12th 114,676 Wicklow Joint 13th
13th 103,277 Clare 8th
14th 101,821 Louth 20th
15th 101,546 Waterford Joint 20th
16th 80,339 Kilkenny Joint 10th
17th 71,858 Westmeath 23rd
18th 63,663 Offaly Joint 24th
19th 58,774 Laois Joint 20th
20th 58,200 Sligo 9*
21st 56,546 Cavan 16th
22nd 53,774 Roscommon Joint 18th
23rd 52,593 Monaghan Joint 10th
24th 46,014 Carlow 26th
25th 31,068 Longford Joint 24th
to °B
-
25,799 Leitrim 17*
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4.2.1 Response Frequency
Surprisingly, Leitrim which is considered to be a low radon county showed the 
highest response frequency (54.3), i.e., cases per 100,000 although with a 
population o f only 25,799 a few cases more or less would skew the results for this 
county. Mayo, which is a high radon county, had the second highest response 
frequency with (36.6), followed by Sligo, again a high radon county with a rate o f 
34.4. Monaghan was fourth with a rate o f (34.2) and Donegal came fifth with a 
rate o f (27.6).
The five counties with the lowest response frequency were Kildare (7.9), Louth 
(10.8), Dublin (10.9), Carlow (10.9) and Offaly (11.0), mostly considered low 
Radon emitting counties with the exception o f Carlow and parts o f Louth.
Response Frequency
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Fig. 4.3 Response Rate/100,000 o f MS by County
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4.2.2 Interferon Use
Interferon is prescribed for MS patients and data from GMS Payments Board 
show a distribution as per fig. 4.4. There are some similarities with fig 4.3, the 
five counties with the highest usage o f interferon are: Leitrim at (158.9), Dublin 
(124.9), Wicklow (108.1), Kildare (107.3) and Sligo (106.5).
Waterford showed the lowest usage o f interferon (37.4) followed by Offaly (39.3), 
Roscommon (40.0), Mayo (46.8) and Cavan (47.7). Table 4.3 shows all the data 
for responses by county, response rate/100,000, interferon users, interferon 
rate/100,000, and percentage o f interferon users. The higher the figure is in 
column 6, the more accurate the data is for that county.
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Fig. 4.4 Usage rates fo r  Interferon
The usage rates for Dublin, Kildare and Wicklow are not accurate as there are 963 
out o f 1,703 interferon users that were not categorised by county in data received
Interferon Usage
—r  
4020 60 80 10 0  12 0  
Interferon Usage per 100,000
14 0 16 0
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from GMS (P) Board. However, when the 963 unallocated people with MS are 
distributed among the three counties based on population statistics, i.e. Dublin 
with a population o f 1,122821 will get 80% or 770, Kildare with a population o f 
163,994 gets 12% or 115 and Wicklow with a population of 114,676 gets 78. 
These adjusted figures are shown in red in table 4.3.
Table 4.3 Counties by Questionnaire Response, Response Rate/100,000, 
Interferon Users, Interferon Rate/100,000, and percentage o f Interferon Users, e.g. 
Carlow with 5 cases by Questionnaire expressed as a percentage o f 35 interferon 
users = 14.2%
ilue = high green = low
County Cases byQ
Response 
Frequency 
Rate 
/100,000
Interferon
Users
Interferon Rate
/100,000
%of
Interferon
Users
Carlow 5 W L 35 76.1 14.2
Cavan 15 26.5 27 m 55.5
Clare 21 20.3 54 52.3 38.8
Cork 73 16.3 365 81.5 20.0
Donegal 38 27.6 144 104.7 26.3
Dublin 122 1,402 124.9 8.7
Galway 31 14.8 170 81.3 18.2
Kerry 23 17.4 88 66.4 26.1
Kildare 13 ■ 176 107.3 7.3
Kilkenny 18 22.4 40 49.8 45.0
Laois 11 18.7 29 49.3 37.9
Leitrim 14 U K 1 41 158.9 34.1
Limerick 28 16.0 135 77.0 20.7
Longford 7 22.5 25 80.5 28.0
Louth 11 ■ 70 68.7 15.7
Mayo 43 36,6 55 m 78.1
Meath 16 11.9 71 53.0 22.5
Monaghan 18 34.2 32 60.8 60.0
Offaly 7 11.0 25 ■ 28.0
Roscommon 13 24.2 21 m 61.9
Sligo 20 34.4 62 106.5 32.2
Tipperary 16 11.4 72 51.4 22.2
Waterford 11 m 38 ■ 28.9
Westmeath 8 n.i 35 48.7 22.8
Wexford 17 14.6 85 72.9 20.0
Wicklow 16 14.0 124 m 12.9
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When one considers that Interferon is the main drug prescribed to people 
diagnosed with MS, and that MS is a long term illness and therefore the cost o f 
drugs is borne by the State (€2,132,496 from June ’02 to June ’03, and €2,492,200 
from June ’03 to June ’04) it is probably safe to assume that not many pay for 
drugs for MS. That being the case, deductions can be made as to the percentage o f 
people with MS who replied to the questionnaire, e.g., Carlow with 5 replies and 
35 people on interferon, approximates to 14%, whereas Clare with 21 replies out 
o f 54 people on interferon approximates to 38%. The total number o f people on 
interferon is 3,422 (GMS (P) Board June ’03), which only represents 
approximately half the total number o f estimated people with MS countrywide. 
Furthermore, not every case o f MS is considered suitable for Interferon, type and 
stage o f MS has to be considered.
4.2.3 MS Cases Plotted on Radon Map
At first glance, there appears to be a haphazard spread o f MS cases, as per fig 4.5, 
(the blue dots represent second home addresses. These were only tised, where the 
respondent spent most o f their childhood, or where the second address was in an 
area with a similar radon level). When the information is transferred to the map 
of Ireland showing radon areas, as per fig 4.6, there appears to be a definite trend. 
There are considerably more MS cases clustered in the darker areas o f the map 
than in the lighter areas, with the exception o f Monaghan, west Clare and perhaps 
Leitrim.
This matter will be discussed further (cf Chapter 6 below), where prevalence rates 
for each county will be estimated.
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Fig. 4.5 M S cases plotted on map o f Ireland
Note: The blue dots represent second home addresses and as can be seen from the 
illustration are more confusing that illustrative.
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RADON IN 
IRISH DWELLINGS
# •
Fig. 4.6 Distribution o f M S Cases plotted on Radon map o f Ireland
A black dot represents each respondent’s childhood home address. Larger 
coloured pins (Dublin) were used to represent multiple respondents’ addresses.
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4.3 G en d er
Of the 671 responses, 29.2% (n = 196) were male, 64.2% (n = 431) were female 
and 6.6 % (n = 44) gave no indication. Of the 627 respondents who indicated 
gender 31.3% were male and 68.7% were female. This represents a ratio of female 
to male o f 2.2:1 which concurs with previous studies as mentioned in para 2.1.8.2 
where ratios ranged from 1.3:1 to 2.8:1. The seemingly higher ratio reported in 
this study could be due to the propensity o f women to attend their doctor more 
regularly than men (Gilmore, pers comm.).
Table 4.4 Response by Gender
Gender Frequency = N Percent Valid Percent
Male 196 29.2 31.3
Female 431 64.2 68.7
Sub total 627 93.4
No response 44 6.6
Total 671 100.0 100.0
EE2
I
EES
m
male female missing
Fig. 4.7 Respondents by Gender
60
4.4 Year Diagnosed and Age at Diagnosis
The earliest diagnosis was made in 1949 and the latest was in 2003. In the 20-year 
period between 1949 and 1968, cases reported in this study as diagnosed per year 
were in single figures, totalling 24 cases. This low figure could be because 
diagnostic capabilities were not as good then as they are now, or because there 
may be less people alive today with MS who were diagnosed in this period. In the 
20-year period between 1969 and 1988, those responding were still low, mostly in 
single figures (14 years out o f the 20 year period registered single figures) varying 
from 3 cases in 1971 to 19 cases in 1980. Total cases in this period amounted to 
242. The 14-year period from 1989 to 2003 accounted for the bulk o f responses, 
with 366 cases in this period. This is quite a jump from the previous periods, and 
may be due to better diagnostic capabilities or greater levels o f exposure to indoor 
radon due to home improvements. (Aluminium and uPVC windows and doors 
began to proliferate the country from the early 1980’s). The year with the most 
cases diagnosed was 1999 with 42 cases. The youngest age at diagnosis was 3 
years and the oldest was 74 years, the median age was 38 years and the average 
age was 36.8 years. Again previous studies concur, Cottrell et al. (1999) reported 
a mean age o f onset o f 38.5 years in para 2.1.8.1. Not surprisingly 62% n = 418 of 
cases reported being diagnosed between the ages o f 27 and 47
CD CO CD-fc» cn 05CO CD —*
Fig. 4.8 Year Diagnosed
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Table 4.5 Age at Diagnosis
Age at 
Diagnosis
Frequency
40 19
41 17
42 14
43 17
44 20
45 22
46 14
47 22
48 15
49 9
50 7
51 12
52 15
53 8
54 5
55 10
56 4
57 4
58 1
59 3
60 3
62 1
63 1
67 2
74 1
Sub total 623
Missing 48
Total 671
Age at 
Diagnosis
Frequency
3 1
4 2
14 1
15 2
16 4
17 2
18 10
19 7
20 6
21 5
22 10
23 7
24 15
25 19
26 13
27 21
28 21
29 14
30 26
31 22
32 21
33 18
34 20
35 17
36 23
37 21
38 23
39 26
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4.5 Family Diagnosed
Over 22% (n = 152) o f  respondents had a family member with MS. This is higher 
than the average o f approximately 15%, (Compston, 1999). In addition some 
respondents reported second, and even third cousins with the disease. One 
hundred female respondents reported having 135 relatives with MS, 61 female, 33 
male, (a ratio o f  1.8:1) and 41 o f unspecified gender. Forty five male respondents 
reported having 52 relatives with MS, 30 female and 12 male, (a ratio o f 2.5:1) 
and 10 o f unspecified gender.
Seven respondents o f  unspecified gender reported having 8 relatives with MS, 1 
male, 4 female and 3 o f  unspecified gender.
Table 4.6 Family Diagnosed
Family Diagnosed Frequency = N Percent Valid Percent
Yes 152 22.7 24.7
No 463 69.0 75.3
Sub total 615 91.7
Don’t  know 25 3.7
No response 31 4.6
Total 671 100.0 100.0
y e s
t~ l n o  
I I M i s s i n g
Fig. 4.9 Family Diagnosed
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Respondents reported sixty three first degree relatives, (mother, father, brother 
and sister) with MS. Fifty six respondents reported having an affected relative 
living in the same house.
One hundred and fifteen respondents reported having one relative with MS, 
twenty-four respondents had two relatives with MS, six respondents had three 
relatives with MS and two respondents had four relatives with MS. One 
respondent reported having six relatives with MS.
Table 4.7 Relatives with MS
Relatives with MS Frequency = N Male Female Unspecified
1 115
2 24
3 6
4 2
5 0
6 1
Total 195 46 95 54
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4.6 Type  o r  H ouse
Almost 40% (n = 263) o f  respondents lived in single storey houses, while 53.9% 
(n = 362) lived in two storey houses. There was no response to that question from
6.9% (n = 46) respondents. Therefore, o f  the 625 respondents to that question 
42.1% spent their childhood in single storey houses.
Table 4.8 Type o f House
Type of House Frequency = N Percent Valid Percent
Single 263 39.2 42.1
Two storey 362 53.9 57.9
Sub total 625 93.1
No response 46 6.9
Total 671 100.0 100.0
□  single  
Ml tw o storey  
m issing
Fig. 4.10 Type o f House
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4.7 Age of H ouse
O f the 588 respondents who indicated the type o f  home they were raised in over 
85% were raised in homes built prior to 1960, with 45.2% being raised in homes 
built before 1920. Approximately 3% (n = 18) respondents reported living in 
homes with a basement.
Table 4.9 When House Built
When House Built Frequency = N Percent Valid
Before 1920 266 39.6 45.2
1921 -  1960 239 35.6 40.6
1961 -  1980 70 10.4 11.9
Since 1980 13 1.9 2.2
Sub total 588 87.6
Don’t know 32 4.8
No response 51 7.6
Total 671 100.0 100.0
300-
250-
200-
1 5 0 -
100-
50-
0
before 1920 1921-1960 1961-1980 after 1980 missing
Fig. 4.11 When House Built
4.8 Water  Supply
There was a fairly even divide between private and public water supplies. O f the 
600 respondents who indicated a water supply over 50% (n = 303) o f  homes had a 
public water supply while 45% (n = 273) had either private or group water scheme 
supplies.
Table 4.10 Water Supply
W ater Supply Frequency = N Percent Valid Percent
Group 52 7.7 8.7
Private 221 32.9 36.8
Public 303 45.2 50.5
More than one 24 3.6 4.0
Sub total 600 89.4
Don’t know 25 3.7
No response 46 6.9
Total 671 100.0 100.0
■ group ^  more than 
private one 
□  public □  missing
Fig. 4.12 Water Supply
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4.9 Toilet  Facilities
Over 55% (n = 371) reported having indoor flush toilets in their homes, with 6.7% 
(n = 45) reporting outhouse flush type. Almost 15% (100) reported having a dry 
toilet and 11% (n = 74) had none. Over 5% (n = 37) had a combination o f the 
above and 6.6% (n = 44) did not respond to that question.
Table 4.11 Toilet Facilities
Toilet Facilities Frequency = N Percent Valid Percent
Indoor flush 371 55.3 59.2
Out-house flush 45 6.7 7.2
Dry 100 14.9 15.9
None 74 n o 11.8
More than one 37 5.5 5.9
Sub total 627 93.4
No response 44 6.6
Total 671 100.0 100.0
Fig. 4.13 Toilet Facilities
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4.10 Heating  Systems
O f the 622 respondents who answered this question over 70% (n = 462) reported 
having a range or open fire as the main heating system. Oil fired accounted for 
5.5% (n = 34), gas 3.4% (n = 21) and electric storage 0.6% (n = 4). Just over 16% 
(n = 101) reported a combination o f systems.
Table 4.12 Heating Systems
Heating System Frequency = N Percent Valid Percent
Oil fired 34 5.1 5.5
CJas 21 3.1 3.4
Electric storage 4 0.6 0.7
Range/open fire 462 68.9 74.2
More than one 101 15.1 16.2
Sub total 622 92.7
No response 49 7.3
Total 671 100.0 100.0
■  oil fired
■  gas 
electric 
storage 
range/open 
fire
combination
missing
Fig. 4.14 Heating Systems
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4.11 Type of Fuel
Over 18% (n = 116) o f  the 605 respondents to this question reported burning turf 
only, and almost 18% (n = 108) reported burning coal. Wood and briquettes 
accounted for just over 3% (n = 19). Over 60% (n = 367) used a combination o f 
fuels.
Table 4.13 Type o f Fuel
Type o f Fuel Frequency = N Percent Valid Percent
Turf 116 16.5 18.3
Coal 108 16.1 17.9
Wood 14 2.1 2.3
Briquettes 5 0.7 0.8
Mixture 367 54.7 60.7
Sub total 605 90.2
No response 66 9.8
Total 671 100.0 100.0
Fig. 4.15 Type o f Fuel Used
4.12 A ir  Flow /Draught
O f the 621 respondents who responded to this question over half 53.1% (n = 330) 
reported living in draughty homes, with another 20.8% (n = 129) living in very 
draughty homes. A  sizeable proportion, 20.5% (n = 127) reported living in homes 
that were not draughty and 5.6% (n = 35) were uncertain.
Table 4.14 Air Flow/Draught
Air Flow Frequency = N Percent Valid Percent
Very draughty 129 19.2 20.8
A  bit draughty 330 49.2 53.1
Not draughty 127 18.9 20.5
Uncertain 35 5.2 5.6
Sub total 621 92.5
No response 50 7.5
Total 671 100.0 100.0
■  very draughty 
a  bit draughty 
not draughty 
uncertain 
missing
Fig. 4.16 Air Flow Draught
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4.13 Type of W indows
There were 617 responses to this question and almost 80% (n = 493) o f these 
reported having wooden windows, with over 50% (349) having wooden sash type 
and over 20% (n =144) having wooden opening out type. The remainder reported 
having aluminium, uPVC, single or double glazed.
Table 4.15 Type o f Windows
Window Type Frequency =N Percent Valid Percent
Wooden sash 349 52.0 56.5
Wooden opening 144 21.5 23.3
Double glazed 43 6.4 7.0
Single glazed 48 7.2 7.8
Other 33 4.9 5.4
Sub total 617 92.0
No response 54 8.0
Total 671 100.0 100.0
72
4.14 Type o f  Schools
Almost 65% (n = 402) o f  the 621 respondents who replied to this question 
reported attending single storey schools, while just over 35% (n = 219) attended 
two storey schools, while 7.5% (n -  50) did not respond to that question.
Table 4.16 Type o f Schools
Type of School Frequency = N Percent Valid Percent
Single storey 402 59.9 64.7
Two storey 219 32.6 35.3
Sub total 621 92.5
No response 50 7.5
Total 671 100.0 100.0
■  single 
two storey 
missing
Fig. 4.17 Type o f Schools
4.15 Age of Schools
O f the 541 respondents to this question who indicated a school age, almost 90% 
(n = 483) attended a school built prior to 1960, with over half 54.9% (n = 297) 
attending a school built prior to 1920. Less than 10% or respondents attended 
schools built after 1980.
Table 4.17 Age o f Schools
When School Built Frequency = N Percent Valid Percent
Before 1920 297 44.3 54.9
1921 -  1960 186 27.7 34.4
1961 -  1980 57 8.5 10.5
Since 1980 1 0.1 0.2
Sub total 541 80.6
Don’t know 81 12.1
No response 49 7.3
Total 671 100.0 100.0
■  before 1920 
m 1921-1960 
El 1961-1980
■  after 1980
□  missing
Fig. 4.18 Age o f Schools
4.16 Water Supply to  Schools
Just over 70% (n = 488) o f control group responded to this question and o f these 
28% (n = 137) reported either group or private as being the water source. By far 
the greatest majority, over 70% (n = 342) reported having a public water supply in 
their school, while 1.8% (9) had no water supply.
Table 4.18 Water Supply to Schools
Water Supply Frequency = N Percent Valid Percent
Group 46 6.9 9.4
Private 91 13.5 18.6
Public 342 51.0 70.2
None 9 1.3 1.8
Sub total 488 72.7
Don’t know 128 19 1
No response 55 8.2
Total 671 100.0 100.0
400“
group private public none missing
Fig. 4.19 Water Supply to Schools
4.17 Toilet  Facilities  at Schools
There were 625 replies to this question and over half (n = 345) o f these indicated 
indoor flush toilets, with outdoor flush accounting for over 16% (n = 104). Almost 
24% (n = 149) reported having dry toilets, with 0.7% (5) reporting having none.
Table 4.19 Toilet Facilities at Schools
Toilet Facilities Frequency = N Percent Valid Percent
Indoor flush 345 51.4 55.3
Out-house flush 104 15.5 16.6
Dry 149 22.2 23.8
None 5 0.7 0.8
More than one 22 3.3 3.5
Sub total 625 93.1
No response 46 6.9
Total 671 100.0 100.0
4 0 0 -
3 0 0 -
200-
100-
out house flush none missing
Fig. 4.20 Toilet Facilities at Schools
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4.18 Heating  Facilities in  Schools
Over 46% (n = 268) o f the 579 respondents to this question reported as having 
had either range or open fire as the heating system, oil fired accounted for over 
35% (n = 212), a small amount 8.3% (n = 48) reported having electric storage 
heaters as the heating system. Gas heating accounted for 1.7%  (n = 10).
Table 4.20 Heating Facilities in Schools
Heating System Frequency = N Percent Valid Percent
Oil fired 212 31.6 36.6
Gras 10 1.5 1.7
Electric storage 48 7.2 8.3
Range/open fire 268 39.9 46.3
More than one 41 6.1 7.1
Sub total 579 86.3
No response 92 13.7
Total 671 100.0 100.0
Fig.
■ oil fired 
gas
■  electric storage 
□  range/open fire
■  combination 
HI Missing
4.21 Heating Facilities in Schools
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4.19 Type of  Fuel used by Schools
The responses to this question were quite low, with only 305 people responding to 
it, of these 15.6% (n = 104) reported turf as being the fuel used to heat the school 
and 10.6% (n = 71) used coal, while 17.4% (n = 117) used a combination of solid 
fuels. Quite a large number of respondents did not reply to this question 54% (n = 
366)
Table 4.21 Type of Fuel used by Schools
Type of Fuel Frequency = N Percent Valid Percent
Turf 104 15.6 34.1
Coal 71 10.6 23.3
Wood 13 1.9 4.3
Mixture 117 17.4 38.3
Sub total 305 45.5
No response 366 54.5
Total 671 100.0 100.0
4 0 0
300
200
100
Fig. 4.22 Type o f Fuel Used by Schools
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4.20 Am Flow/Draught at Schools
Almost 45% (n = 273) of the 615 respondents who responded to this question, 
reported attending schools that they considered a bit draughty, while 27% (166) 
reported being in very draughty schools and over 16% reported attending schools 
that were not considered draughty.
Table 4.22 Air Flow/Draught at Schools
Air Flow Frequency = N Percent Valid Percent
Very draughty 166 24.7 27.0
A bit draughty 273 40.8 44.4
Not draughty 102 15.2 16.6
Uncertain 74 11.0 12.0
Sub total 615 91.7
No response 56 8.3
Total 671 100.0 100.0
■  very draughty
■  a  bit draughty 
HI not draughty
■  uncertain
Fig. 4.23 Air Flow/Draught at Schools
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4.21 Type o f  W indows in  Schools
There were over 600 replies to this question with over 67% (n = 406) indicating 
that their school had wooden sash windows, with over 18% (n =112) having 
wooden opening out type.
Table 4.23 Type o f Windows in Schools
Window Type Frequency =N Percent Valid Percent
Wooden sash 406 60.6 67.1
Wooden opening 112 16.7 18.5
Double glazed 8 1.2 1.4
Single glazed 46 6.8 7.6
Other 33 4.9 5.4
Sub total 605 90.2
No response 66
Total 671 100.0 100.0
8 0
5. RADON LEVELS
5.1 Radon L evels
Of the 615 respondents who indicated their home county during their first fifteen 
years, almost 13% (n = 84) spent their first fifteen years living in an area, where 
greater than 20% of homes are predicted to have radon levels in excess o f the 
National Reference level of 200Bq/m3, (Radon Level 6).
Just under 3% (n = 16) spent their childhood in areas that are predicted to have 
15% of homes above the reference level o f 200Bq/m3, (Radon Level 5).
Over 12% (n = 84) came from areas where between 10 -  15% of homes are 
predicted to exceed the reference level of 200Bq/m3, (Radon Level 4). See Table
5.1.
Therefore, almost 30% (n = 184) of respondents spent their childhood in 
areas that are considered high Radon areas by RPII.
Author is not suggesting that respondents spent their childhood in homes with 
high Radon Levels; however they did spend their childhood in high Radon areas 
and therefore may have been exposed to high levels of Radon.
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Table 5.1 Distribution of Cases by County and by Radon Level
Radon Levels
County 6 5 4 3 2 1 Total
Carlow 5 5
Cavan 2 5 8 15
Clare 3 1 5 1 2 9 21
Cork 1 5 13 17 29 8 73
Dublin 44 63 15 122
Donegal 1 8 1 6 22 38
Galway 14 5 3 3 4 2 31
Kerry 5 1 2 6 9 23
Kildare 3 1 7 2 13
Kilkenny 8 2 2 6 18
Laois 2 1 6 2 11
Leitrim 1 13 14
Limerick 1 8 17 2 28
Longford 3 4 7
Louth 5 1 3 2 11
Mayo 18 1 9 6 9 43
Meath 6 1 2 2 5 16
Monaghan 2 2 14 18
Offaly 1 2 4 7
Roscommon 1 4 4 4 13
Sligo 11 1 1 1 4 2 20
Tipperary 2 3 6 5 16
Waterford 8 1 2 11
Westmeath 1 3 4 8
Wexford 5 6 1 5 17
Wicklow 6 5 2 3 16
Total 84 16 84 101 182 148 615
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Logically, one can assume that if an area (10 km grid square) has been classified 
as a high Radon area, then all the people with MS and all other unexplained 
ailments can cite exposure to Radon as being the harbinger of disease. However, 
that’s not scientific, but out of the top three counties by response 
frequency/100,000 of MS, two of them, namely Sligo and Mayo also happen to be 
high Radon counties. Leitrim is considered a low Radon county and as mentioned 
previously (4.2.1) with its low population, one or two cases more or less could 
skew the results. Furthermore, looking at the three counties, reflecting the lowest 
response frequency/100,000, Kildare, Dublin and Louth, both Dublin and Kildare 
are considered as low Radon areas, with Louth being in the mid range. The 
population of Louth by virtue of its proximity to Sellafield Nuclear Processing 
Plant may be subject to higher levels of ionizing radiation. Perhaps it is just a 
coincidence that there are more MS cases clustered in high Radon areas, the main 
exception being Monaghan. The findings presented in this thesis have to be 
considered in light of the literature presented about MS and Radon. They also 
have to be considered in light of what is unknown about MS and Radon.
Further analysis will demonstrate that the risk of developing MS is greater in the 
areas with a high radon level. Galway, Mayo, Sligo, Wicklow, Carlow and 
Wexford all have known high Radon levels, while Tipperary, Leitrim, Offaly, 
Laois, Kildare and Cavan, are all considered low Radon emitting counties. 
Looking at the percentages of MS cases in each of the Radon Levels in these 
counties it can be postulated that the likelihood of developing MS is greater in the 
higher Radon level areas.
Take Sligo for example, where the author lives and works, 55% of MS cases 
reported are in Radon level 6, with only 10% reported in Radon level 1. Wicklow, 
Galway and Mayo all have at least 40% of reported MS cases in Radon level 6. 
Conversely, take Leitrim for example, 93% of its reported MS cases are in Radon 
level 1 and the other 7% in Radon level 2. As mentioned previously, Leitrim with 
its relatively low population, one or two cases more or less could skew the results. 
Table 5.2 below shows the approximate percentage of MS cases in each Radon 
level.
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Table 5.2 Percentage o f MS cases by questionnaire in each Radon Level
County Radon Levels Total MS Cases
6 5 4 3 2 1
% % % % % %
Galway 44 18 9 9 15 5 31
Mayo 42 2 21 14 21 43
Sligo 55 5 5 5 20 10 20
Wicklow 40 26 14 20 16
Carlow 100 5
Wexford 29 36 6 29 17
Waterford 73 9 18 11
Meath 37 6 13 13 31 16
Louth 45 9 28 18 11
Kerry 21 4 8 26 39 23
Westmeath 13 37 50 8
Roscommon 7 31 31 31 13
Monaghan 11 11 78 18
Longford 43 57 7
Limerick 4 28 60 8 28
Clare 14 5 24 5 9 43 21
Dublin 36 52 12 122
Cork 2 7 18 22 40 11 73
Kilkenny 45 11 11 33 18
Donegal 3 22 3 15 57 38
Tipperary 12 19 38 31 16
Leitrim 7 93 14
Offaly 14 28 58 7
Laois 15 8 54 23 11
Kildare 23 8 54 15 13
Cavan 12 31 57 15
Counties shaded in blue are considered to be high Radon emitting counties and 
the comities shaded in green are considered to be low Radon emitting counties. 
However, it was not possible to take Radon measurements o f respondent’s 
chi/dho(xJ homes as part o f this study. (See recommendation 8. f)
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6 . D i s c u s s i o n
6.1 D iscussion
In this study, there were areas that were not studied, e.g., childhood viruses or 
genetics. The author accepts that genes play a vital role in the onset of MS, 
(Chatway et al., 2001 and Zhou et al., 2003)) but for this study the childhood 
environment was the main focus of study. Although the home environment of 
respondents was not measured for Radon as part o f this study, the discussion 
therefore is based on circumstantial evidence of Radon exposure leading to 
conjecture and conclusions. This study set out to ascertain if there was any 
connection between onset of MS and childhood exposure to Radon. Having 
reviewed the literature and findings, it seems reasonable to propose that there is a 
connection and furthermore, if this risk is eliminated then MS may be preventable 
in some if not all of its forms.
The fact that the identical twin of a person with MS, sharing all the same genes, does 
not always develop MS, and that upwards of 80% of people with MS do not have a 
first degree relative with MS, strongly suggests that genes are not the only factor 
involved in developing MS. The pattern of MS inheritance has not been clearly 
defined. If genes were the only factor in developing MS, the identical twin of a 
person with MS should always get MS.
6.2 Inc id en ce
The steady rise in the incidence of MS with the passing of time, Fig. 6.1 (as per 
Fig 4.8) is graphically displayed and there seems to be little doubt that there is a 
steady rise. From 1949 up to the early 1970’s there appears to be a steadily rising, 
low incidence of MS. Then the numbers increased significantly up to the early 
1990’s. As mentioned in 4.4 this could be because the diagnostic capabilities 
improved, or there were more people alive with MS in this period or there are 
more people contracting MS.
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Then there appears to be another shift upwards. This could be attributed to the 
steady rise in home improvements that were carried out since the 1970’s and right 
up to the present. It is also reasonable to assume that home improvements were 
carried out in homes of people who now have MS, given that 45% of those who 
responded to the questionnaire lived in homes that were built prior to 1920 and 
that another 40% lived in homes that were built between 1921 and 1960.
Y e a r  D ia g n o s e d
Fig. 6.1 Year Diagnosed
Donegal, although seemingly a medium radon (4% n = 18 out of 487 
measurements taken had Radon levels greater than the safe reference level o f 200 
Bq/m3) area seems to have a higher than average response frequency. I suspect 
that this might be due more to genetics than environment. Traditionally, people 
from Donegal migrated to Scotland to work and will probably have intermarried
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with people of Scottish descent and as Scotland has one of the highest prevalence 
rates in the world there are probably more Scottish people carrying the genes that 
are responsible for the development of MS. This mixing of the genes may have 
contributed to the higher than expected prevalence rate in Donegal. McGuigan et 
al. (2004) reported a prevalence rate for Donegal of 184.6/100,000
6.3 H ome Improvements
Home improvements usually include new draught proof windows and doors. 
Obviously this means that there will be less home air exchanges per hour. This, in 
an area that is considered a high Radon area is likely to lead to greater exposure to 
Radon. Bowie and Bowie (1991) suggest that draught proofing and double glazing 
may lead to a 30% increase in Radon levels. In another study, the highest 
concentrations of Radon were found during the winter months when there is less 
ventilation and central heating is used, (Law, Kane, Roman, Smith, and 
Cartwright, 2000).
6.4 W inter
In the winter months more time is spent indoors and exposure to Radon will be 
greater. This is significant, as a recent study by Wilier, Dyment, Sadovnick, 
Rothwell, Murray and Ebers, (2005) has shown that there is an association 
between month of birth and the risk of developing MS. The study found for the 
northern hemisphere that for the month of May there was a 13% increase in risk 
of MS compared with November. The study also suggests a reversal for MS 
patients bom in the southern hemisphere. This would mean that the mother 
carrying the developing foetus during the winter months was more likely to be 
indoors for the greater portion of the pregnancy and consequently be exposed to 
Radon for longer periods.
As mentioned previously in para 2.2.5.2, Radon is more soluble in tissues with a 
high fat content. Both bone marrow and the female breast have a high fat content 
and consequently receive the highest dose of all tissues outside the lung. Stem 
cells, which develop into all types of tissue in the body, originating in the bone
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marrow may be harmed by exposure to Radon. The evidence presented by Zhou, 
et al., (2000), showed that a single alpha particle can induce mutations and 
chromosome aberrations in cells that receive no direct radiation exposure to their 
DNA. Wilier, et al., (2005) also support the suggestion that the gestational and/or 
neonatal environment influence the risk of MS in later life. A developing foetus is 
quite a delicate organism and exposure to elevated levels of radiation during this 
stage is probably not the best start in life.
6.5 Water
Over 45% of respondents depended on ground water for their domestic supply and 
the RPII concluded in their report on Radon in drinking water in Wicklow (2003) 
“that Radon in drinking water may pose a significant additional health risk, in the 
longer term, to certain consumers who depend on drinking water supplies derived 
from groundwater as their primary source of drinking water” . Bottle feeding of 
infants and/or breast feeding in such areas is likely to be a further health risk to 
the developing infant and as Kendall and Smith (2002) noted, that water with a 
high Radon content if ingested can remain in the stomach quite a while before it is 
passed to the small intestine and the on to the blood stream.
6.6 H ome Environment
Another significant finding is that over 40% of respondents spent their childhood 
in single storey houses. Radon being nine times heavier than air is therefore more 
likely to be a health hazard in single storey houses, particularly for children who 
spend quite a lot time in their first few years very close to the ground. Even in 
draughty homes, at night when doors and windows are usually closed there is 
likely to be a build-up of Radon and consequently more exposure to it. Children in 
the first ten years of their lives spend quite a large proportion of time indoors and 
again, there is the likelihood of further Radon exposure. Modern homes that have 
no Radon barriers or Radon remediation measures taken, and are tightly sealed, 
well insulated, single storey and built on uranium rich soil are quite frankly, 
health hazards.
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Fig 6.2 Percentage o f dwellings by county that exceeded the reference level 
(Source RPII)
6.7 Schools
Outside the home, school buildings are where children are most likely to spend 
most of their time. The majority of respondents (over 60%) attended single storey 
schools, and Fig 6.2 shows the percentage of schools with one or more rooms 
above the reference level of 200 Bq/m3. Galway was found to have the highest 
number of schools with one or more rooms above the reference level, with 43% of 
schools falling into this category. Also over 70% of respondents from Galway 
lived in the upper Radon level areas, 6, 5, and 4, as per Table 5.1, and over 60% 
also lived in single storey houses. Over 70% of Galway respondents also indicated 
that their water supply was from groundwater, with over 50% indicating a private 
well as being the water supply. The response frequency rate for Galway was low 
at just 14.8/100,000, but it had one of the lowest response rates at just 6.4%. 
Figures similar to Mayo would be expected with an improved response rate.
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Fig. 6.3 Percentage o f schools by county with one or more rooms above reference 
level (Source RPII)
Mayo, with almost 30% of its schools having one or more rooms above the 
reference level also had 65% of its respondents living in the upper Radon level 
areas and over 60% living in single storey houses. Over 50% of Mayo respondents 
indicated groundwater as their supply with over 40% indicating a private well as 
being the supply. The clustering of MS cases is quite evident (fig. 4.6) but not 
exclusive, for both these counties. The response frequency rate for Mayo was 
second highest at 36.6/100,000 and Mayo also had the second highest response 
rate at 30%.
Kildare had 18% of its schools with one or more rooms above the reference level 
and over 75% of its respondents living in Radon level areas, 3, 2, and 1, with over 
50% or its respondents living in single storey houses. The response frequency rate 
for Kildare was the lowest at just 7.9/100,000, although it also had a low response 
rate of 7.1%.
90
Cavan had only 6% of its schools with one or more rooms above the reference 
level and 100% of respondents lived in the lower Radon level areas, 3, 2, and 1 
and over 50% of its respondents lived in single storey houses. The response 
frequency rate for Cavan seemed higher than expected at 26.5/100,000 and it also 
had a high response rate of 19.2%. However, with its relatively low population, a 
few cases plus or minus could skew results for this county.
6.8 Age at Diagnosis
The was no apparent difference noted in age at diagnosis in areas of differing 
Radon levels for females. However, there was a difference for males, with average 
age of diagnosis of 38.4 in Radon level 1 areas and average age of diagnosis of
29.8 in Radon level 5 areas and average age of 33.5 in Radon level 6 areas. In 
Radon level 5 and Radon level 6 areas males are being diagnosed approximately 7 
years earlier than in the other Radon level areas. This would seem to suggest that 
there is a significant or critical level at which Radon exposure can cause harm to 
young males. In the areas where greater than 15% of homes are predicted to have 
Radon levels above the reference level, it seems that males are being diagnosed at 
a younger age with MS than males in the areas where less than 15% of homes are 
likely to have elevated Radon levels. Table 6.1 shows the average ages for both 
males and females for each Radon level area.
Table 6.1 Average Age at Diagnosis
Average age at diagnosis
Radon Levels Male Female
1 38.4 35.3
2 38.4 36.7
3 38.8 37.4
4 38.6 36.1
5 29.8 37.4
6 33.5 36.8
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6.9 Canada
As pointed in 2.1.8.4, Canada displayed the fifth highest global prevalence rate for 
MS and is included here because there are startling differences in prevalence rates 
among native indigenous Canadians and the immigrant community. This again 
would suggest that the risk factor is genetic and/or environmental. Native 
Canadians, e.g., Eskimos have very low incidence rates of MS, but the incidence 
among the mainly European settlers is very high. The difference between these 
two communities is that Eskimos live predominately outdoor nomadic lives on 
ice, and ice cover inhibits Radon emissions (Conen, 2003). They will also have a 
narrower gene pool. Settlers live static indoor lives with the hazard of exposure to 
Radon, and will have evolved from a mixed European community with a larger 
gene pool. The fact that MS is not unknown among the Eskimo community proves 
that the defective gene or genes are present in their gene pool, and therefore one 
could speculate that Radon is a factor in the high prevalence rates within the 
immigrant community.
6.10 Estimated Prevalence Rate
The estimated prevalence rate was derived at by comparing the results in this 
study (see table 6.2) with the data in McGuigan et al. (2004). They established 
that there were 240 MS cases in Co. Donegal giving a prevalence rate of 
184.6/100,000 and 126 MS cases in Co. Wexford, giving a prevalence rate of 
120.7/100,000. The ratio o f cases therefore for Donegal to Wexford is 1.904:1. 
This figure was compared to the MS News distribution list, which showed that 
Donegal had 186 members and Wexford had 97 members. The ratio o f MS 
members for Donegal to Wexford is 1.917:1. Furthermore, when the response 
frequency rates (RFR) in this study were examined for Donegal and Wexford, 
which were 27.6 and 14.6 respectively, they showed a ratio of 1.890:1. Even more 
strikingly, when the RFR for Donegal and Wexford in this study were divided into 
the number of cases identified in McGuigan et al. (2004), Donegal with 240 cases 
identified divided by the RFR in this study of 27.6, a ratio of 8.69 is the result. 
Similarly for Wexford with 126 cases identified, divided by RFR of 14.6, a ratio 
of 8.63 results. Therefore, by using the prevalence rates in McGuigan et al. 
(2004), and the RFR in this study, the author was able to estimate a prevalence
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rate for the country. This was achieved by establishing the ratios between the 
prevalence rates in (McGuigan et al. 2004) and the RFR (this study) for Wexford 
and Donegal (184.6 divided by 27.6 = 6.68 and 120.7 divided by 14.6 = 8.26 and 
averaging the two answers gives a figure of 7.47, rounded up to 7.5) and using the 
resulting average figure of 7.5 as a multiplier for the RFR to arrive at an estimated 
prevalence rate for the country. However, Leitrim by virtue of its exceedingly 
high RFR coupled with its low population, was excluded, and consequently all 
other counties that had a lower percentage response rate than Leitrim at 14.2% 
(Table 4.1). That left eight counties namely, Cavan, Clare, Cork, Donegal, Dublin, 
Kilkenny, Mayo and Wexford. These eight counties account for 2,182,429 
persons or 56% of the population of Ireland. When the RFR for these eight 
counties were multiplied by 7.5 and the resulting answers were totalled and 
divided by 8 the result was 164.25. Therefore, according to this study the 
estimated prevalence rate for Ireland is calculated as 164.25/100,000. If the 
reported prevalence rates in McGuigan et al. (2004) for Donegal and Wexford are 
averaged the result is 152.65/100,000 and if the same is done for this study the 
result is 158.25/100,000. It was also noted that the eight counties with the highest 
estimated prevalence rates, namely Leitrim, Mayo, Sligo, Monaghan, Donegal, 
Cavan, Roscommon and Longford all border each other and are more or less in 
the North West of the island of Ireland.
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County Population CSO MS News Dist
MS News Dist. 
Rate per 100,000 Cases by Q
Response 
Frequency Rate 
per 100,000
Interferon
Use Rate per 100,000
Estimated MS 
Prevalence Rate 
per 100,000
Kildare 163,994 181 110.3 13 7.9 176 107.3 59.2
Louth 101.821 101 99.1 11 10.8 70 68.7 81.0
Waterford 101,546 186 183.1 11 10.8 38 37.4 81.0
Dublin 1,122,821 797 70.9 122 10.9 1402 124.9 81.7
Carlow 46,014 139 302.0 5 10.9 35 76.1 81.7
Offaly 63,663 85 133.5 7 11.0 25 39.3 82.5
Westmeath 71,858 83 115.5 8 11.1 35 48.7 83.2
Tipperary 140,131 193 137.7 16 11.4 72 51.4 85.5
Meath 134,005 148 110.4 16 11.9 71 53.0 89.2
Wicklow 114.676 123 107.2 16 14.0 124 108.1 105.0
Wexford 116,596 97 83.1 17 14.6 85 72.9 109.5
Galwav 209,077 480 229.5 31 14.8 170 81.3 111.0
Limerick 175,304 469 267.5 28 16.0 135 77.0 120.0
Cork 447,829 423 94.4 73 16.3 365 81.5 122.2
Kerry 132,527 380 286.7 23 17.4 88 66.4 130.5
Laois 58.774 179 304.5 11 18.7 29 49.3 140.2
Clare 103,277 64 61.9 21 20.3 54 52.3 152.2
Kilkenny 80,339 83 103.3 18 22.4 40 49.8 168.0
Longford 31,068 86 276.8 7 22.5 25 80.5 168.7
Roscommon 53,774 195 326.6 13 24.2 21 40.0 181.5
Cavan 56,546 78 137.9 15 26.5 27 47.7 198.7
Donegal 137,575 186 135.1 38 27.6 144 104.7 207.0
Monaghan 52,593 193 366.9 18 34.2 32 60.8 256.5
Sligo 58,200 156 268.0 20 34.4 62 106.5 258.0
Mavo 117,446 139 118.3 43 36.6 55 46.8 274.5
Leitrim 25,799 98 379.8 14 54.3 41 158.9 407.2
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Table 
6.2 
Estim
ated 
Prevalence 
R
ate
Table 6.3 Facts and Statements in Summary Form
Multiple Sclerosis Facts Radon Facts Statement
It affects approximately 
twice as many females as 
males
It is harmful when it 
becomes trapped in 
buildings
Females traditionally 
spend more time in 
the home than males
The myelin coating on the 
nerves is the target for 
destruction in MS
It is soluble in fat
Myelin is a fatty 
substance, as is bone 
marrow and the 
female breast
It is most common amongst 
Caucasian people of 
northern European origin
Ice cover inhibits its 
emissions
MS is rare amongst 
Eskimos
It is more prevalent in 
temperate regions than in 
tropical regions
It is considered harmless 
in the atmosphere
It is rare amongst 
people who live 
outdoor nomadic lives
It is a complex genetic 
disorder
It is a radioactive gas and 
emits alpha particles 
when it decays
A single alpha particle 
can induce mutations 
and chromosome 
aberrations in cells 
that receive no direct 
radiation exposure to 
their DNA
There is no known cause It is a known carcinogenic
Radon?
Hypothesis: Exposure 
to Radon during the 
first 15 years of life 
may be one of the 
environmental triggers 
that is responsible for 
the onset o f MS in 
later life
Multiple Sclerosis Beliefs
It is believed that an 
environmental trigger in the 
first 15 years of life is 
responsible for its onset
It is generated by the 
decay of uranium within 
the earths crust and 
ascends to the 
atmosphere
Radon is in the 
environment
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7. CONCLUSIONS
The initial aims of this study were to:
a. To establish the prevalence of MS in Ireland: - this aim was not
realised. Due to ethical considerations full co-operation from the 
country’s neurologists was not possible I am however, very 
appreciative of the co-operation received. It is difficult for a non­
medical researcher to obtain access to medical data. However, to 
circumvent this problem an estimated prevalence rate of 
164.25/100,000 (see para 6.9) was calculated based on data from 
McGuigan et al. (2004), which reported prevalence rates for 
Donegal and Wexford.
b. To establish the environmental milieu of MS patients for the
first 15 years of their lives: - this aim was achieved. However, 
one of the more interesting findings, although more from a 
sociological point of view was the fact that, 100 respondents 
reported having a dry toilet (one wonders how many of today’s 
students know what a dry toilet is), and an even more startling 
revelation, was, that 74 respondents reported having no toilet.
c. To plot this information geographically: - this aim was achieved
and for the most part there were no real surprises. A trend was 
recognised whereby there appears to be more clustering of MS 
cases in the areas of Ireland, where it is known that there are high 
radon levels.
d. To examine the relationship between the incidence of MS and
factors increasing exposure to natural radiation within the 
built environment, (specifically -  indoor radon).- this aim was 
also achieved; as the author infers that there is a relationship 
between MS and exposure to indoor radon. Given what is known 
about MS and what is known about Radon, especially the lack of 
data about how the human body, from conception to maturity, 
reacts to exposure to radon and its progeny, then, unless it can 
unequivocally be ruled out as being the environmental trigger that 
precipitates the onset of MS, it must be treated as if it could be one
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of the environmental triggers. Environmental factors that have 
been ruled out include; exposure to Zinc, childhood illnesses, 
canine distemper, slow viruses, sinusitis, herpes zoster, herpes 
simplex and climate, (Martyn, 1991). However it was also noted 
that climate has an influence on many aspects of a population e.g. 
house design, and that differences in one or more of these could 
provide the mechanism for environmental triggers to influence the 
onset of MS. Martyn (1991 p.35) concludes with “epidemiologists 
now need to formulate specific hypotheses about causal 
environmental factors”. A recent American study has shown a 
strong potential causality relationship between MS and exposure to 
ionising radiation, (Eidbo and Prater, 2004). That study found high 
prevalence rates of MS in US counties that also had high indoor 
Radon levels. Extremely high prevalence rates were found in the 
States of Washington and Idaho and both had high indoor radon 
levels. The study also noted low prevalence rates coinciding with 
low indoor radon levels, and to advance the radon connection, 
cases of MS were reported as being rampant among National Park 
Service personnel at the Mammoth Hot Springs, Yellowstone 
National Park headquarters in the late 1980’s. Radon ground 
readings there reached 1,000 p/Ci/1, or 200 times the 
Environmental Protection Agency health standard, (Eidbo and 
Prater, 2004)
e. If the hypothesis is proven - to alert national authorities as to 
what preventative or mitigating actions can be taken: - no, the
hypothesis is not proven beyond all reasonable doubt. There are 
still too many unknowns to say without doubt that the hypothesis is 
proven. However, perhaps there is enough circumstantial evidence 
to form an educated guess. A number o f respondents have given 
permission for measurements to be taken in their childhood homes. 
The technology to make accurate retrospective Radon 
measurements is available even if the homes have been
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modernised. This can be achieved provided the glass in the 
windows is original.
The US Congress, in 1988 passed an Act entitled “The U.S. Radon 
Abatement Act”. This Act directed that the EPA identify and 
measure indoor Radon levels in each of the 3,141 counties in the 
U.S.A. To date 18,000,000 homes across the United States have 
been tested for Radon and Almost 800,000 have had remedial 
measures taken to reduce the occupants’ exposure to Radon 
(Gregory and Jalbert, 2003). The U.S. Congress recognises the 
threat to public health that Radon poses. In Ireland 11,319 homes 
have been measured by the RPII in the national radon survey.
This present study now adds to the body of knowledge that 
recognises the threat to public health from continued exposure to 
indoor Radon. Already the relevant authorities know this, as there 
are building regulations directing that Radon preventative 
measures be taken in all new homes in known high radon areas. 
These regulations came into force on the 1st July 1998. If these 
regulations are applied fully, the author would expect to see a 
decline in the incidence of MS over the next twenty to thirty years, 
perhaps back to the levels observed before home improvements 
with double glazing and draught proofing, trapped Radon in 
homes.
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8. RECOMMENDATIONS
Any measures aimed at reducing the hazard of Radon exposure should include:-
a. A government sponsored measuring of all homes in known high Radon 
areas.
b. Grant assisted remedial measures to eliminate Radon exposure in homes 
that have elevated Radon levels.
c. A raising of the level of awareness of Radon and its perceived health 
related risks. The apathy shown towards Radon is probably because it is 
invisible and therefore not perceived as a threat to health. On the other 
hand, radiation is known to be dangerous, even though it cannot be seen.
d. As not enough is known about Radon and its perceived health related 
risks, a multifaceted Radon research plan is needed.
e. The author would also concur with Dr. Colgan of the RPII, in 
recommending that as part of the home buying process that a Radon 
Survey be included in the architectural survey of the house.
f. The author recommends that radon measurements be taken in the homes of 
respondents that gave permission.
g. Given the economic burden of MS on the state, the author definitely 
recommends that MS becomes a notifiable disease, as should all diseases, 
and that more use be made of mapping illnesses. After all mapping disease 
is nothing new. In 1848 when John Snow mapped the incidence of Cholera 
in Soho, London it was observed that there was a clustering of Cholera 
cases around a water pump in Broad Street. Once this pump was shut 
down the epidemic of Cholera subsided rapidly. Obviously the more that is 
known about a disease the greater the chances are of finding a cure, if not 
preventing it altogether. The mystery of MS can only be solved by 
continued painstaking research and full co-operation between all the 
interested parties.
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Appendix 1
Institiuid Teicneolaiochta, Sligeach 
INSTITUTE OF TECHNOLOGY, SLIGO 
Ballinode, Sligo, Ireland.
Stiurthoir/Director: Richard Thom, BA (Mod), MA, PhD, MCIWEM 
Tel: 353 71 55222 Fax: 353 71 45704
Dear Dr.____________
I am carrying out research for a Masters Degree (A study of the prevalence 
o f Multiple Sclerosis and its relationship with the natural/geological 
environment), under the supervision of
Eamonn Grennan (geologist -  School o f Science) Institute o f Technology, Sligo 
and
Margaret Gilmore (medical doctor -  Social Studies Department) Institute of 
Technology, Sligo.
As you are aware, Multiple Sclerosis is considered likely to have an 
environmental component in addition to a genetic predisposition and so the first 
objectives of the study are
1. to establish the prevalence of MS in Ireland
2. to establish the natural environmental milieu for the first 15 years of
life o f people who have MS.
Background Information
The northwest of Ireland appears to have one of the highest prevalence rates of 
MS in Ireland, but as yet there is no reliable database. The area is one of the
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highest radon emitting areas in Ireland with Donegal in particular containing some 
of the most highly uranium enriched granites in the country. This has provided the 
motivation for the pilot study that was undertaken by E. Grennan and M. Gilmore 
i.e. an attempt to refine the well known geographical association between MS and
temperate climates to a more coherent association between MS and geology.
It is in relation to objective one that I feel that you can be of great assistance to my 
study, as we need to survey MS patients to establish their home townlands during 
childhood. As the majority o f patients surveyed in the pilot study (a copy of which 
can be made available to you on request), had not moved from their childhood 
home or locality, it would be of great help to us if you could let us have a printout 
of their present townland. I realise that there may be ethical and legal 
considerations that may cause problems in divulging such information. If this is 
not directly possible, I am quite happy to carry it out in a mutually acceptable 
manner. However, given that this is a worthwhile research project which will fill a 
major void in our medical statistics I feel that these problems should not be 
insurmountable. Also, I would like to stress at this time that any information 
furnished will be treated confidentially and will not be used for any other purpose. 
A copy of this survey will be made available to you when it is completed.
I have also written to the Health Boards and the MS Society of Ireland, from 
which I expect to get people to take part in the survey to fulfil the second
objective as outlined above.
Should you require any further information, please do no hesitate to contact me at
Public Health Department 
North Western Health Board 
3rd Floor, Bridgewater House 
Sligo
Phone -  071 74762 or email -  denis.carroll@nwhb.ie 
or
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Denis Carroll
Department of Business and Humanities
Institute of Technology
Sligo
Kindest Regards 
Yours Sincerely
Denis Carroll
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Appendix 2
MULITIPLE SCLEROSIS and 
RADON: Is there a connection? 
*Eamonn Grennan
BJSc., M.Sc., Dtfiyj Admin.Sc.
M argaret Gilmore
B.Ch., B,A.O., D.C:H.,D.Obs.
Denis Carroll b.a.
B ackground
*  In s t i tu te  o f T echno logy , Sligo 
a>¡E n v i ro n rne ntaI Scienge
*  30 yea rs  w o r ld -w id e  expe rience  
G eo logy and Living
Initial Interest 
• B o lv iken  (1 9 9 7 )
^ M a g n e s iu m  and fish ea ting  w j th  low 
p reva lence  o f  MS
High p reva lence  o f  MS w ith  Radon 
e m a n a t in g  f ro m  g ra n ites  in N orw ay  
"T h a t  th e  c o n te n t  o f  Rn in inha led  a ir  
is a risk fa c to r  in MS"
(N e u ro ep il  20.0.3:)
Geology and Health
ASBESTOSIS 
• COAL MINER'S LUNG DISEASE 
•* Rn and LUNG DISEASE 
ZEOLITES and CARCINOMA
T opics Requiring F o cu s
•  Radon
• G eology 
E n v iro n m e n t
• Maps
Early Studies
B u m f ie ld (1 9 9 1 )  and R ob inson (1998 )  
;> M edline and Acta. Neur. Scand.
MCAIpine's M u lt ip le  Sclerosis
; La t i tud ina l Effect- 
E n v iro n m e n ta l  T r ig ge r
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MS Distribution
♦ La t i tud ina l e f fe c t  = G eologica l E ffect
* Europe South  to  North  
USA S o u the as t  to  N or theas t 
A us tra l ia  Queens land  to  Tasm ania
Miller in N 1.(1966)
«- 2 areas o f  h igh inc idence ” H" & "D "  
v NIPB High Rn in M ourne  Mtns
• M ourne  Mtns -  " ro c k  is S i lu r ian , the  
soil b row n  pod sot ic"
Sperr in  Mtns -  ' ' rock  is m a in ly  sch is t ,  
th e  soil b row n  podso lic "
Irish data
• Sligo - v e ry  h igh Rn va lues
Donegal - s ign i f ican t U d iscover ies
W ick low  - Rn in w a te r  recen t 
red iscove ry
Britain
'C o m p s to n  and S w in g le r (1 9 8 6 )  
Prevalence ra te  fo r  UK increases N
• A pp le ton  and B a l l (1 9 9 5 )
Rn m ap fo r  Br ita in
Reviewing evidence to date
Redefined in f luence o f  Rn to inc lude 
ion is ing rad ia t ion
European D a ta ­
it Aberdeen  - g ra n i te  c ity  
O rkneys  - m a jo r  U e xp lo ra t io n  e f fo r t  
Sard in ia  - unusa l ly  h igh MS, h ighes t 
indoo r  beguere l c o u n t  in Europe
MS p uzzle
Cause u n k n o w n , p ro bab ly  m u lt i -  
fac to r ia l  inc lud ing  e n v i ro n m e n ta l  
age n t
Prevalence in te m p e ra te  la t itudes  is 
high
1 1 8
E nvironm ental a g e n t
T r ig g e r  fo r  MS be fo re  age 15 e.g. 
M ig ra t ion  a f te r  age 15 years  -  
MS ra te  rem a in s  as fo r  area o f  o r ig in
G eo g rap h y
Areas of high MS prevalence are underlain 
by rocks of
- Same age (300-500rn. years old)
.. Similar mineral composition
- High radon emission 
e.g.
-Orkneys (>250/100,000)
- N.E. Scotland"'(> 170/100,000)
-N. Ireland (>130/100,000)
R a c e  vs P lace
♦ 'Low incidence of MS among 
Eskimos, Bantus and Gypsies -
live outdoor,  nomadic lives in low 
radon areas.
Other  links
" e n v i ro n m e n ta l  fac to rs  .. possible 
t r ig g e rs  fo r  va r ious  a u to im m u n e  
d iso rde rs  e.g.
.--Ultraviolet ra d ia t io n .and MS 
Io n is ing  rad ia t ion  and SLE. .
H eavy m eta ls  and a u to im m u n e  
g lo m e ru lo n e p h r i t is "  (N IHS 1999)
H Y P O T HE SI S
T h a t  r i sk  o f  d e v e l o p i n g  MS 
(If g e n e t i c a l l y  s u s c e p t i b l e )  
is i n c r e a s e d  b y  e x p o s u r e  
t o  n a t u r a l  i o n i s i n g  
r a d i a t i o n  b e f o r e  a g e  1 5  
y e a r s
Study 1
.> M em bersh ip  o f  MS Socie ty  o f  I re la nd  
on co un ty  basis
-B ro a d  c o rre la t ion  w ith  areas o f  
g re a te r  radon  em iss ions :
H ow e ve r  -
- S t u d y  needs to be m ore  accura te  
- M a y  no t be to ta l ly  rep re sen ta t ive
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Study 2 Resul t s  of Study 2
Prevalence (u n q u a n t i f je d )  was th o u g h t  
to  be high ini.NW Ire land
A q u e s t io n n a ire  s u rv e y  o f users o f  
N.W. M.S. Therapy Cen tre  show ed :
Resul t s  (contd.)
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used open  f ires fo r  hea t ing
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Open fire Central healing Other heating system
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70.0V:
3S SVo 37 0% 27 AW Sarnpio
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Flush Dry None
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Use o f  open f ires ( tu r f  tends  to 
co nce n tra te  rad ioac t ive  e le m e n ts )
$n .thffesurvey; if i iwas no t possible 
to te s t  radon levels
Conc l us i ons
• These p ilo t s tud ies  b road ly  s u p p o r t  
hypo thes is
F u r th e r  w o rk  is needed
H Y P O T HE SI S
❖ T h a t  r i sk  o f  d e v e l o p i n g  MS 
(if g e n e t i c a l l y  s u s c e p t i b l e )  
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y e a r s
1 2 1
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We need to  a d m in is te r  q ue s t ion na ire  
to as m any  people  w ith  MS as 
possible
-G a n  p reserve  c o n f id e n t ia l i ty  if done 
via consu ltan ts  
-  Nat iona l MS p re va le nce  ra te
IF H Y P OT H ES I S  IS TRUE
• Fu ture  research needs will be
h igh l igh ted
• Anti radon s tra teg ies :
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Ire land
L o n g te r m  b en e f i t  o f MS p re v e ntion
1 2 2
Institiüid Teicneolaiochta, Sligeach 
INSTITUTE OF TECHNOLOGY, SLIGO 
Ballinode, Sligo, Ireland.
Tel: 353 71 91 55222 Fax: 353 71 91 45704
P o s t a l  Q u e s t i o n n a i r e
Dear Reader
I would like to invite you to take part in research into a possible cause of 
Multiple Sclerosis. I am trying to find out if there is any relationship between 
developing Multiple Sclerosis and the presence of Radon in the environment. 
Radon is a naturally occurring gas, which can reach high levels inside buildings.
I am particularly interested in your childhood home(s)/school(s) up to age 15 
years.
Results of the survey will be made available to MS News.
As a gesture to acknowledge your participation in this survey, a donation will be 
made to the Multiple Sclerosis Society of Ireland for each completed 
questionnaire returned by January 31st 2004.
This research project (A study o f the prevalence o f Multiple Sclerosis and its 
relationship with the natural/geological environment in Ireland) has been 
approved by the IT Sligo Research Ethics Committee and your participation is 
voluntary.
Thank you for your help. Please return the completed questionnaire to me at the 
address below, or in the envelope provided.
Appendix 3
S u q e A C
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Yours Sincerely
Denis Carroll B. A.
School of Business and Humanities 
Institute of Technology 
Ballinode 
Sligo
email carroll.denis@itsligo.ie 
Phone: 071 91 55307 (direct line)
I would like to acknowledge assistance from the NWHB and IT Sligo for 
their financial and practical support in this research project.
Any information given will be only be used by the researcher 
and will not be made available to any other person or institution 
without the consent of the giver. The results may be published 
but no individual will be identified. All details will be securely 
stored.
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Q 1. Date of Birth
Section I  -  Personal
M □  F □
Q 2. When were you diagnosed with Multiple Sclerosis? 19____
Q 3. Has anyone else in your family been diagnosed with Multiple Sclerosis?
Yes na No nb Don’t know nc 
If yes, for each blood relative, please describe relationship, e.g. aunt (mother’s sister, fathers 
sister, etc.), for each case.
Did this person(s) live in the same house(s) as you? Yes □ No □
Section  n  - Accommodation
Please complete the following détails for each house (or other accommodation) you 
have lived in from birth to 15 years of age.
I f  you have lived in more than one house, please include details on separate sheet i f  
necessary.
Q 4. Address (including townland/district)_________________________________
Q 5. Length o f time living there
Q 6. When was the house built (approx) -  please tick one box
Before 1920 □ Between 1921 and 1960 □
Between 1961 and 1980 □ After 1980 □
Don’t know □
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Q 7. Type of House -  please tick one box
Single storey □ Two storey or more □
Q.8 Was/is there a basement in this house ? YesD Noa
Q 9. Where was the water supply taken from? -  please tick all that apply
Group water scheme □ Private well □
Public supply □ Don’t know □
Q 10. Type of toilet facilities -  please tick all that apply
Indoor flush toilet □ Outhouse flush toilet □
Dry toilet □ None □
Q 11. Heating System -  please tick all that apply
Oil fired central heating □ Gas central heating □
Electric storage heaters □ Range /Open fire □
Q 12. If heating system was range/open fire please indicate type of fuel 
Turf □ Coal □ Wood □ Peat Briquettes □
Q 13. Would you describe the house as?
Very draughty □ A bit draughty □
Not at all draughty □ Uncertain □
Q 14. Types of windows -  please tick as appropriate
Wooden sash □ Wooden -  opening out □
Aluminium □ uPVC □
Single glazed □ Double glazed □
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Section m  -  Schools attended and/or places of work up to age 15
Q  15. N am e &  address (including tow nland)__________________________
For subsequent schools or 'workplaces please include details on separate sheet i f  necessary.
Q 16. Length of time spent there -  from/to approx___________________________
Q 17. When was the school built? (approx) -  please tick one box
Before 1920 □ Between 1921 and 1960 □
Between 1961 and 1980 □ After 1980 □
Don’t know □
Q 18. Type of school -  please tick one box
Single storey □ Two storey □
Q. 19 Was/is there a basement in this school? Yesa Non
Q 20. Where was the water supply taken from? -  please tick all that apply 
Group water scheme □ Private well □
Public supply □ Don’t know □
Q 21. Type of toilet facilities -  please tick all that apply
Indoor flush toilet □ Outhouse flush toilet □
Dry toilet □ None □
Q 22. Heating System -  please tick all that apply
Oil fired central heating □ Gas central heating □
Electric storage heaters □ Range /Open fire □
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Q 23. If  heating system was range/open fire please indicate type o f fuel 
Turfo Coal a  Wood □ Peat Briquettes □
Q 24. Would you describe the school as?
Very draughty □ A bit draughty □
Not at all draughty □ Uncertain □
Q 25. Types o f windows -  please tick as appropriate
Wooden sash □ Wooden -  opening out □
Aluminium □ uPVC □
Single glazed □ Double glazed □
Section IV  -  O p tiona l
If you are still living in your childhood home and the survey shows a strong connection, may 
we contact you in the future to discuss Radon levels? If  yes, please leave your present 
contact details.
Yes □  No □
Name______________________________________
Address ___
Thank you for taking the time to complete this questionnaire. 
P l e a s e  r e t u r n  q u e s t i o n n a i r e  b y  J a n  3 1 2 0 0 4 .
A ny in fo rm a tio n  g iv e n  w ill b e  o n ly  b e  u s e d  b y  th e  r e s e a r c h e r  a n d  w ill n o t  b e  
m a d e  a v a i la b le  to  a n y  o th e r  p e r s o n  o r  in s t i tu t io n  w ith o u t  th e  c o n s e n t  o f  th e  
g iv e r. T h e  r e s u l t s  m a y  b e  p u b l is h e d  b u t  n o  in d iv id u a l w ill b e  id e n tif ie d . All 
d e ta i ls  w ill b e  s e c u r e ly  s to r e d .
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Appendix 4
Institiuid Teicneolaiochta, Sligeach 
INSTITUTE OF TECHNOLOGY, SLIGO 
Ballinode, Sligo, Ireland.
Stinrthoir/Director: Richard Thorn, BA (Mod), MA, PhD, MCIWEM Tel: 353 71 55222 Fax: 353 71 45704
Dear
As you are aware, Multiple Sclerosis is considered likely to have an 
environmental component in addition to a genetic predisposition. My reason for writing 
to you is, I am carrying out research for a Masters Degree (A study of the prevalence of 
Multiple Sclerosis and its relationship with the natural/geological environment), under 
the supervision of
Eamonn Grennan (geologist -  School of Science) Institute of Technology, Sligo 
and
Margaret Gilmore (medical doctor -  Social Studies Department) Institute of Technology, 
Sligo.
The first objectives of the study are
3. to establish the prevalence of MS in Ireland
4. to establish the natural environmental milieu for the first 15 years of life of
people who have MS.
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Background Information
The northwest of Ireland appears to have one of the highest prevalence rates of MS in 
Ireland, but as yet there is no reliable database. The area is one of the highest radon 
emitting areas in Ireland with Donegal in particular containing some of the most highly 
uranium enriched granites in the country. This has provided the motivation for the pilot 
study that was undertaken by E. Grennan and M. Gilmore i.e. an attempt to refine the 
well known geographical association between MS and temperate climates to a more 
coherent association between MS and geology. A copy of this pilot survey can be made 
available on request.
I have written to the country’s neurologists and asked them to furnish me with the 
locations by townland of all their patients. However, this is unlikely to be detailed 
enough, therefore in order to carry out a survey to achieve the second objective I need 
your assistance in distributing a questionnaire to all of your members. It would be 
preferable if I could carry this out myself, but if this is not possible then I am quite happy 
to carry it out in a mutually acceptable manner. Any information supplied will be treated 
confidentially and will not be disclosed to anyone else. A copy of the survey results will 
be sent to you when it is completed.
Should you require any further information, please do no hesitate to contact me at
Public Health Department 
North Western Health Board 
3rd Floor, Bridgewater House
Sligo
Phone -  071 74762 or email -  denis. carroll@,nwhb. ie 
or
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Denis Carroll
Department of Business and Humanities
Institute of Technology 
Sligo
Kindest Regards 
Yours Sincerely
Denis Carroll
131
Appendix 5
Sl ig o  Stu d y  l in k s  R a d o n  G as t o  M S
The above headline was printed in the Sunday Times on December 15th 2002. It was the 
result of a study carried out by Eamonn Grennan, a geologist and environmental scientist 
and Margaret Gilmore, a medical doctor and social studies lecturer, both lecturing at the 
Sligo Institute of Technology. Perhaps this headline is too dramatic, you may say. Where 
is the proof? Well, that is where this article and YOUR involvement come in.
My name is Denis Carroll and I am a research student, studying at the Institute of 
Technology, Sligo. I am currently involved in a detailed, nationwide study trying to 
ascertain whether exposure to indoor Radon can be considered one of the environmental 
factors that triggers the onset of Multiple Sclerosis, (it is agreed that genetically 
susceptible individuals are exposed to some environmental trigger). You can help me by 
completing the enclosed questionnaire, which will contribute to the countrywide picture 
of Multiple Sclerosis.
Below are the main points from the initial pilot survey. I hope to build on this study with 
the data obtained from these questionnaires. In the pilot study, the questionnaire was 
designed to ascertain the environmental milieu of people who have MS. There were 
questions on house type, house age, types of facilities, Le. heating, water supply and 
sanitation.
There is considerable variation in the prevalence of multiple sclerosis around the world 
and this geographical distribution has been studied in the hope that some clues as to the 
cause of the disease will be unearthed. The prevalence of Multiple Sclerosis increases 
with latitude north and south of the equator. There are various theories as to why this 
might be, too numerous to go into in this article.
There were two studies carried out. The first one examined the membership of MS 
Society in Ireland and as expected the higher prevalence rates correlated with the general 
pattern of higher radon emissions as surveyed by the Radiological Institute of Ireland, i.e.
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a band of lower prevalence through the country from Kenmare to Drogheda. The second 
study was via a questionnaire distributed with the help of the Northwest MS Therapy 
Centre.
R e s u l t s  o f  P il o t  Stu d y
Of the 66 respondents, almost two thirds were female In addition; almost half of female 
respondents had a relative with MS, as did one fifth of males.
The average age of onset for males was 27.9 years, while the average age at diagnosis 
was 35 years, whereas for females the average age of onset was higher at 33.4 years with 
average age at diagnosis 38.3 years. The average time span from onset to diagnosis for 
males was 7 years with the longest spell being 26 years, while for females the average 
was lower at 5 years with the longest spell being 16 years.
Over two thirds of respondents lived in single storey houses and the majority spent their 
early years in houses built prior to 1960. Over half had a private water supply, (Radon is 
found in water). Almost three quarters had an open fire (probably burning turf).
D is c u s sio n
As there were no actual radon measurements carried out in any of the respondents’ homes 
it cannot be said with any degree of certainty that exposure to indoor radon during the 
first fifteen years of life has been a contributing factor. However, most authorities on MS 
agree that exposure to some environmental agent in genetically pre-disposed individuals 
up to the age 15, may result in development of MS.
Over half of respondents spent the first 15 years of their lives in the counties Donegal, 
Sligo and Mayo. To assist in identifying areas at greatest risk of high indoor radon levels, 
the Radiological Protection Institute of Ireland, which has responsibility for the detection 
and measurement of radon gas in Ireland, initiated a national geographically based radon 
survey in 1992. The county with the largest proportion of high radon houses measured 
was County Sligo where 20% of the houses exceeded the Reference Level. This and the 
fact that over two thirds of respondents spent the early years of their lives in single 
storey, older type houses could also point to radon being one of the environmental
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triggers. Radon gas can become trapped in buildings, especially older type buildings that 
have had no radon extraction works carried out, and is nine times heavier than air. It can 
become trapped in homes especially during the night when there is little airflow in 
bedrooms. This exposure over a long period can have health implications. For the first 
time, researchers have found direct evidence that the occurrence of radon in people’s 
homes may account for 1 in 20 cases of lung cancer in the UK. Radon is also known to be 
soluble in fat. Myelin is a fatty substance that insulates the nerves and it is the breakdown 
and subsequent scarring of this tissue that is responsible for the distortion or even 
blocking of messages from the brain that lead to the symptoms of MS.
Co n c l u s io n
Given what is known about Radon and its distribution throughout Ireland, it is clear that 
it could be one of the environmental factors that trigger MS in genetically susceptible 
individuals. The feet that over half of the respondents spent the first 15 years of their 
lives in homes located in areas known to have higher than average indoor radon levels 
and over two thirds lived in single storey homes, it seems logical to suggest that indoor 
Radon can be considered to be one of the environmental triggers. However, a nationwide 
study, mapping the incidence of the disease would shed even more light on the mystery 
surrounding this debilitating disease and if the hypothesis is proven, we could take 
preventative action to lessen the number of future cases.
This current study aims to do just that, via a refined questionnaire, which is included in 
this issue of MS News. It has been over twenty-five years since anyone has tried to 
establish the national prevalence rate and this study aims to rectify that situation while 
trying to correlate it with Radon exposure. The more that is known about a disease, the 
more likely a cause, or a cure can be identified.
Denis Carroll 
Research Assistant
Institute of Technology, Ballinode, Sligo
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Appendix 6
Report on breakdown of Multiple Sclerosis Patients as at June 2003-10-02 
GMS(P) Board September 2003
Health Board Population
No. of Patients on 
Interferon
County/City
ERHAHB 467 Dublin City
1,122,821 165 Dublin County
163,994 61 Kildare
114,676 47 Wicklow
963 *Unallocated
Total 1703
Midland HB
58,774 29 Laois
31,068 25 Longford
63,663 25 Offaly
71,858 35 Westmeath
Total 114
Midwestern HB
103,277 54 Clare
175,304 69 Limerick City
66 Limerick County
32 Tipperary N.R
Total 221
North Eastern HB
56,546 27 Cavan
101,821 70 Louth
134,005 71 Meath
52,593 30 Monaghan
2 Carrickmacross
Total 200
North Western HB
135
137,575 144 Donegal
25,799 41 Leitrim
58,200 62 Sligo
Total 247
South Eastern HB
46,014 35 Carlow
80,339 40 Kilkenny
140,131 40 Tipperary S R.
11 Waterford City
101,546 27 Waterford County
116,596 85 Wexford
Total 238
Southern HB
447,829 201 Cork City
160 North Cork
132,527 88 Kerry
4 South Cork
Total: 453
Western HB
209,077 170 Galway
117,446 55 Mayo
53,774 21 Roscommon
Total 246
Total: 3,422
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